VIP (Vasoactive Intestinal Peptide) Peptide

Price range: $59.00 through $71.00

Research-grade VIP (Vasoactive Intestinal Peptide) Peptide for laboratory investigation. For Research Use Only. Not for human use.

Size: No selection

More options

Clear

COA VIP 5mg COA VIP 10mg

For Research Use Only. Not for human use.

Overview

VIP (Vasoactive Intestinal Peptide) Peptide is supplied as a research-grade catalog material for controlled laboratory investigation.

Laboratories choose this item when protocols need clear identification, consistent labeling, and documentation suitable for reproducible experimental workflows.

Catalog packaging and research-use labeling help purchasing and bench teams keep procurement records aligned with the physical vial.

Research Context for VIP (Vasoactive Intestinal Peptide) Peptide

Work involving VIP (Vasoactive Intestinal Peptide) Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

Research-grade material intended for laboratory investigation only
Catalog labeling aligned with research procurement channels
Suitable for method development and comparative assay workflows
Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of VIP (Vasoactive Intestinal Peptide) Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source VIP (Vasoactive Intestinal Peptide) Peptide

Procurement and research teams often select this catalog item because it supports:

Clear research-use labeling for compliance-aligned purchasing
Consistent product identification across multi-lot studies
Fit for reference, screening, and mechanistic laboratory models
Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with VIP (Vasoactive Intestinal Peptide) Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using VIP (Vasoactive Intestinal Peptide) Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of VIP (Vasoactive Intestinal Peptide) Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 963 PubMed records. Displaying 10 per page.

Fahrenkrug J (2010). VIP and PACAP [PMID: 19859678]
Laboratory literature summary: VIP and PACAP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (1984). VIP and diarrhoea [PMID: 6141341]
Laboratory literature summary: VIP and diarrhoea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shaikh H et al. (2022). GVHD: pDCs providing VIP protection [PMID: 36136363]
Laboratory literature summary: GVHD: pDCs providing VIP protection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Juhász T et al. (2015). PACAP and VIP signaling in chondrogenesis and osteogenesis [PMID: 25701761]
Laboratory literature summary: PACAP and VIP signaling in chondrogenesis and osteogenesis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Laburthe M et al. (2002). VPAC receptors for VIP and PACAP [PMID: 12529932]
Laboratory literature summary: VPAC receptors for VIP and PACAP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Morell M et al. (2012). VIP in neurological diseases: more than a neuropeptide [PMID: 23094829]
Laboratory literature summary: VIP in neurological diseases: more than a neuropeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (1991). VIP and the skin [PMID: 1672973]
Laboratory literature summary: VIP and the skin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hill JM et al. (1996). VIP regulation of embryonic growth [PMID: 8993408]
Laboratory literature summary: VIP regulation of embryonic growth. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gozes I et al. (1989). VIP: molecular biology and neurobiological function [PMID: 2698176]
Laboratory literature summary: VIP: molecular biology and neurobiological function. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dudai A et al. (2021). Cortical VIP(+) /ChAT(+) interneurons: From genetics to function [PMID: 33301603]
Laboratory literature summary: Cortical VIP(+) /ChAT(+) interneurons: From genetics to function. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dickinson T et al. (1999). VIP and PACAP: very important in pain? [PMID: 10431211]
Laboratory literature summary: VIP and PACAP: very important in pain?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J (1989). VIP and autonomic neurotransmission [PMID: 2541454]
Laboratory literature summary: VIP and autonomic neurotransmission. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gozes I et al. (2003). VIP and drug design [PMID: 12570811]
Laboratory literature summary: VIP and drug design. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (2004). Neurotransmitters co-existing with VIP or PACAP [PMID: 15134862]
Laboratory literature summary: Neurotransmitters co-existing with VIP or PACAP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Passemard S et al. (2011). VIP-induced neuroprotection of the developing brain [PMID: 21524251]
Laboratory literature summary: VIP-induced neuroprotection of the developing brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Abad C et al. (2018). Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice [PMID: 30105629]
Laboratory literature summary: Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Luis J et al. (1988). The vasoactive intestinal peptide (VIP) receptor: recent data and hypothesis [PMID: 2852963]
Laboratory literature summary: The vasoactive intestinal peptide (VIP) receptor: recent data and hypothesis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Foster N (2012). Editorial: vasoactive intestinal peptide (vip): historic perspective and future potential [PMID: 23094826]
Laboratory literature summary: Editorial: vasoactive intestinal peptide (vip): historic perspective and future potential. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Barnes PJ et al. (1984). VIP and asthma [PMID: 6140418]
Laboratory literature summary: VIP and asthma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Winzell MS et al. (2007). Role of VIP and PACAP in islet function [PMID: 17559974]
Laboratory literature summary: Role of VIP and PACAP in islet function. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Moody TW et al. (2003). VIP as a trophic factor in the CNS and oncology research models cells [PMID: 12576099]
Laboratory literature summary: VIP as a trophic factor in the CNS and oncology research models cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dvoráková MC (2005). Cardioprotective role of the VIP signaling system [PMID: 16247516]
Laboratory literature summary: Cardioprotective role of the VIP signaling system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Magistretti PJ (1990). VIP neurons in the cerebral cortex [PMID: 2200184]
Laboratory literature summary: VIP neurons in the cerebral cortex. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Masmoudi-Kouki O et al. (2007). Role of PACAP and VIP in astroglial functions [PMID: 17655978]
Laboratory literature summary: Role of PACAP and VIP in astroglial functions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rosselin G et al. (1982). A new neuroregulator: the vasoactive intestinal peptide or VIP [PMID: 6290287]
Laboratory literature summary: A new neuroregulator: the vasoactive intestinal peptide or VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Klippstein R et al. (2015). Vasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled… [PMID: 25819279]
Laboratory literature summary: Vasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled and Targeted Drug Delivery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yamaguchi K et al. (1979). Laboratory research record on VIP (Vasoactive Intestinal ) [PMID: 491133]
PubMed laboratory record discussing VIP (Vasoactive Intestinal ) in a research context. Review the full methods and limitations on PubMed; research use only.
Asano S et al. (2025). Dimerisation of the VIP receptor VIPR2 is essential to its binding VIP and Gα(i)… [PMID: 40203889]
Laboratory literature summary: Dimerisation of the VIP receptor VIPR2 is essential to its binding VIP and Gα(i) proteins, and to its functions in breast oncology…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Harmar T et al. (1994). Multiple receptors for PACAP and VIP [PMID: 7912462]
Laboratory literature summary: Multiple receptors for PACAP and VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gomariz RP et al. (2001). Immunology of VIP: a review and therapeutical perspectives [PMID: 11172702]
Laboratory literature summary: Immunology of VIP: a review and therapeutical perspectives. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Laburthe M et al. (2002). Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP [PMID: 12220741]
Laboratory literature summary: Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gozes I et al. (1995). A VIP hybrid antagonist: from developmental neurobiology to laboratory applications [PMID: 8719036]
Laboratory literature summary: A VIP hybrid antagonist: from developmental neurobiology to laboratory applications. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Christophe J et al. (1986). Effector mechanisms of peptides of the VIP family [PMID: 3018687]
Laboratory literature summary: Effector mechanisms of peptides of the VIP family. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zou J et al. (2023). Inhibitory neurons: VIP neurons expect rewards [PMID: 37699349]
Laboratory literature summary: Inhibitory neurons: VIP neurons expect rewards. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chandrasekharan B et al. (2013). Emerging neuropeptide targets in inflammation: NPY and VIP [PMID: 23538492]
Laboratory literature summary: Emerging neuropeptide targets in inflammation: NPY and VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Verma AK et al. (2017). Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in… [PMID: 28964637]
Laboratory literature summary: Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jiang X et al. (2012). The role of VIP in cornea [PMID: 23074208]
Laboratory literature summary: The role of VIP in cornea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pozo D (2003). VIP- and PACAP-mediated immunomodulation as prospective investigational tools [PMID: 12763526]
Laboratory literature summary: VIP- and PACAP-mediated immunomodulation as prospective investigational tools. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Onoue S et al. (2007). Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP)… [PMID: 17537541]
Laboratory literature summary: Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the investigation of asthma/COPD. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Onoue S et al. (2008). Structure-activity relationship of vasoactive intestinal peptide (VIP): potent… [PMID: 18172612]
Laboratory literature summary: Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential laboratory applications. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhu Z et al. (2026). Vip(+) vagal neurons control allergen-induced responses [PMID: 42024502]
Laboratory literature summary: Vip(+) vagal neurons control allergen-induced responses. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gozes I et al. (1999). Pharmaceutical VIP: prospects and problems [PMID: 10519911]
Laboratory literature summary: Pharmaceutical VIP: prospects and problems. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Marchis-Mouren G et al. (1988). HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP… [PMID: 2844304]
Laboratory literature summary: HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sundler F et al. (1977). VIP innervation of the gallbladder [PMID: 858483]
Laboratory literature summary: VIP innervation of the gallbladder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Misery L et al. (2003). [Aquadynia: a role for VIP?] [PMID: 12671583]
Laboratory literature summary: [Aquadynia: a role for VIP?]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1984). Vasoactive intestinal polypeptide (VIP): current status [PMID: 6147814]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP): current status. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hu JS et al. (2023). Tsc1 Loss in VIP-Lineage Cortical Interneurons Results in More VIP+ Interneurons and… [PMID: 38201256]
Laboratory literature summary: Tsc1 Loss in VIP-Lineage Cortical Interneurons Results in More VIP+ Interneurons and Enhanced Excitability. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kaneko M et al. (2024). Stimulus-specific enhancement in mouse visual cortex requires GABA but not VIP-peptide… [PMID: 38774975]
Laboratory literature summary: Stimulus-specific enhancement in mouse visual cortex requires GABA but not VIP-peptide release from VIP interneurons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rosselin G (1986). The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon… [PMID: 3018707]
Laboratory literature summary: The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jackson J et al. (2016). VIP+ interneurons control neocortical activity across brain states [PMID: 26961109]
Laboratory literature summary: VIP+ interneurons control neocortical activity across brain states. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jaffe BM (1979). To be or not to VIP [PMID: 759268]
Laboratory literature summary: To be or not to VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Moody TW et al. (2004). The development of VIP-ellipticine conjugates [PMID: 15518911]
Laboratory literature summary: The development of VIP-ellipticine conjugates. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ekman R et al. (1985). Glucagon and VIP in the retina [PMID: 4044167]
Laboratory literature summary: Glucagon and VIP in the retina. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Batista-Brito R et al. (2017). Developmental Dysfunction of VIP Interneurons Impairs Cortical Circuits [PMID: 28817803]
Laboratory literature summary: Developmental Dysfunction of VIP Interneurons Impairs Cortical Circuits. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Caraglia M et al. (2008). Experimental study on vasoactive intestinal peptide (VIP) and its diaminopropane bound… [PMID: 17619118]
Laboratory literature summary: Experimental study on vasoactive intestinal peptide (VIP) and its diaminopropane bound (VIP-DAP) analog in solution. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1995). PreproPACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP [PMID: 8577931]
Laboratory literature summary: PreproPACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Flood JF et al. (1990). Vasoactive intestinal peptide (VIP): an amnestic neuropeptide [PMID: 2178250]
Laboratory literature summary: Vasoactive intestinal peptide (VIP): an amnestic neuropeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lucas A et al. (1982). Vasoactive intestinal peptide (VIP) in preterm and term neonates [PMID: 7136620]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) in preterm and term neonates. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pozo D et al. (2000). Immunobiology of vasoactive intestinal peptide (VIP) [PMID: 10637552]
Laboratory literature summary: Immunobiology of vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schytz HW et al. (2010). Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP [PMID: 20454993]
Laboratory literature summary: Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Korkmaz OT et al. (2025). Vasoactive Intestinal Peptide (VIP) and its Receptors in Adipose Tissue: Implications… [PMID: 39550744]
Laboratory literature summary: Vasoactive Intestinal Peptide (VIP) and its Receptors in Adipose Tissue: Implications for Cold Stress Adaptation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gozes Y et al. (1991). A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes [PMID: 1647246]
Laboratory literature summary: A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bellinger DL et al. (1996). The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation [PMID: 8790778]
Laboratory literature summary: The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wu J et al. (2022). Cortical VIP(+) Interneurons in the Upper and Deeper Layers Are Transcriptionally Distinct [PMID: 35708842]
Laboratory literature summary: Cortical VIP(+) Interneurons in the Upper and Deeper Layers Are Transcriptionally Distinct. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kingsbury MA et al. (2015). Nesting behavior is associated with VIP expression and VIP-Fos colocalization in a… [PMID: 25573700]
Laboratory literature summary: Nesting behavior is associated with VIP expression and VIP-Fos colocalization in a network-wide manner. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Girard BA et al. (2006). Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes… [PMID: 17029602]
Laboratory literature summary: Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vassiliou E et al. (2001). TH2 lymphocytes secrete functional VIP upon antigen stimulation [PMID: 11935374]
Laboratory literature summary: TH2 lymphocytes secrete functional VIP upon antigen stimulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zeng L et al. (2023). Heme and Cu(2+)-induced vasoactive intestinal peptide (VIP) tyrosine nitration: A… [PMID: 37481062]
Laboratory literature summary: Heme and Cu(2+)-induced vasoactive intestinal peptide (VIP) tyrosine nitration: A possible molecular mechanism for the attenuated…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Granoth R et al. (2000). VIP and the potent analog, stearyl-Nle(17)-VIP, induce proliferation of keratinocytes [PMID: 10858492]
Laboratory literature summary: VIP and the potent analog, stearyl-Nle(17)-VIP, induce proliferation of keratinocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Agnese M et al. (2014). Molecular cloning of VIP and distribution of VIP/VPACR system in the testis of… [PMID: 24753326]
Laboratory literature summary: Molecular cloning of VIP and distribution of VIP/VPACR system in the testis of Podarcis sicula. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Waschek JA et al. (1996). Embryonic expression of vasoactive intestinal peptide (VIP) and VIP receptor genes [PMID: 8627335]
Laboratory literature summary: Embryonic expression of vasoactive intestinal peptide (VIP) and VIP receptor genes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Colwell CS et al. (2003). Disrupted circadian rhythms in VIP- and PHI-deficient mice [PMID: 12855416]
Laboratory literature summary: Disrupted circadian rhythms in VIP- and PHI-deficient mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Parkman HP et al. (1997). PACAP and VIP inhibit pyloric muscle through VIP/PACAP-preferring receptors [PMID: 9350977]
Laboratory literature summary: PACAP and VIP inhibit pyloric muscle through VIP/PACAP-preferring receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhu W et al. (2001). Projections and pathways of VIP- and nNOS-containing airway neurons in ferret trachea [PMID: 11152648]
Laboratory literature summary: Projections and pathways of VIP- and nNOS-containing airway neurons in ferret trachea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hoshino M et al. (1984). Production of VIP- and PHM (research subjects PHI)-related peptides in research… [PMID: 6548020]
Laboratory literature summary: Production of VIP- and PHM (research subjects PHI)-related peptides in research subjects neuroblastoma cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wu J et al. (2022). Ablation of microRNAs in VIP(+) interneurons impairs olfactory discrimination and… [PMID: 34981885]
Laboratory literature summary: Ablation of microRNAs in VIP(+) interneurons impairs olfactory discrimination and decreases neural activity in the olfactory bulb. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gozes I et al. (1986). Structure and expression of the vasoactive intestinal peptide (VIP) gene in a research… [PMID: 3748844]
Laboratory literature summary: Structure and expression of the vasoactive intestinal peptide (VIP) gene in a research subjects oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Allescher HD et al. (1989). Inhibitory function of VIP-PHI and galanin in canine pylorus [PMID: 2468295]
Laboratory literature summary: Inhibitory function of VIP-PHI and galanin in canine pylorus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jiang S et al. (1997). Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1… [PMID: 9108448]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing research subjects pancreatic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wulff BS et al. (1994). Expression and characterization of VIP and two VIP mutants in NIH 3T3 cells [PMID: 8137920]
Laboratory literature summary: Expression and characterization of VIP and two VIP mutants in NIH 3T3 cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Burian B et al. (2010). Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived… [PMID: 20026142]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
De Maria S et al. (2002). Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16… [PMID: 12084061]
Laboratory literature summary: Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates VIP/PACAP receptor activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1977). Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma [PMID: 325156]
Laboratory literature summary: Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ahrén B et al. (1991). Effects of helodermin and VIP on insulin and glucagon secretion in the mouse [PMID: 2003148]
Laboratory literature summary: Effects of helodermin and VIP on insulin and glucagon secretion in the mouse. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Christophe J et al. (1990). VIP receptors in research subjects SUP-T1 lymphoblasts [PMID: 1979777]
Laboratory literature summary: VIP receptors in research subjects SUP-T1 lymphoblasts. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jansen-Olesen I et al. (1994). Vasoactive intestinal peptide (VIP) like peptides in the cerebral circulation of the cat [PMID: 7836694]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) like peptides in the cerebral circulation of the cat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sun W et al. (2000). Vasoactive intestinal peptide (VIP) inhibits TGF-beta1 production in murine macrophages [PMID: 10808055]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) inhibits TGF-beta1 production in murine macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ekström J et al. (2014). Parasympathetic vasoactive intestinal peptide (VIP): a likely contributor to… [PMID: 23731177]
Laboratory literature summary: Parasympathetic vasoactive intestinal peptide (VIP): a likely contributor to clozapine-induced sialorrhoea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yanaihara N et al. (1977). Immunological aspects of secretin, substance P, and VIP [PMID: 838240]
Laboratory literature summary: Immunological aspects of secretin, substance P, and VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bolkent S et al. (1994). Characterization and content of VIP and VIP mRNA in rat fore-brain neurones [PMID: 7938702]
Laboratory literature summary: Characterization and content of VIP and VIP mRNA in rat fore-brain neurones. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cheng L et al. (2010). Progesterone receptor A mediates VIP inhibition of contraction [PMID: 20019164]
Laboratory literature summary: Progesterone receptor A mediates VIP inhibition of contraction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Algazi MC et al. (1989). Effect of VIP antagonist on VIP-, PGE2-, and acid-stimulated duodenal bicarbonate… [PMID: 2719108]
Laboratory literature summary: Effect of VIP antagonist on VIP-, PGE2-, and acid-stimulated duodenal bicarbonate secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yelkenli İH et al. (2016). Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal… [PMID: 27115671]
Laboratory literature summary: Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in neurodegeneration research models Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bryant MG (1978). Vasoactive intestinal peptide (VIP) [PMID: 298740]
Laboratory literature summary: Vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yeomans DC et al. (2003). Conformation-dependent effects of VIP on nociception in rats [PMID: 12860207]
Laboratory literature summary: Conformation-dependent effects of VIP on nociception in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1991). Vasoactive intestinal polypeptide (VIP) in asthma [PMID: 1683200]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) in asthma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vacas E et al. (2012). Vasoactive intestinal peptide (VIP) inhibits research subjects renal cell carcinoma… [PMID: 22728770]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) inhibits research subjects renal cell carcinoma proliferation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Modlin IM et al. (1979). VIP and the WDHA syndrome [PMID: 437409]
Laboratory literature summary: VIP and the WDHA syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gourlet P et al. (1998). Analogues of VIP, helodermin, and PACAP discriminate between rat and research subjects… [PMID: 9928018]
Laboratory literature summary: Analogues of VIP, helodermin, and PACAP discriminate between rat and research subjects VIP1 and VIP2 receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shi Y et al. (2000). [Preparation of 131I-VIP and 131I-VIP receptor imaging] [PMID: 12545811]
Laboratory literature summary: [Preparation of 131I-VIP and 131I-VIP receptor imaging]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Castorina A et al. (2008). PACAP and VIP prevent apoptosis in schwannoma cells [PMID: 18835258]
Laboratory literature summary: PACAP and VIP prevent apoptosis in schwannoma cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Langer I et al. (2001). Vasoactive intestinal peptide (VIP) stimulates [Ca2+]i and cyclic AMPin CHO cells… [PMID: 11587546]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) stimulates [Ca2+]i and cyclic AMPin CHO cells expressing Galpha16. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Whittaker VP (1989). Vasoactive intestinal polypeptide (VIP) as a cholinergic co-transmitter: some recent… [PMID: 2699832]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) as a cholinergic co-transmitter: some recent results. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bodanszky M et al. (1986). Conformation of peptides of the secretin-VIP-glucagon family in solution [PMID: 3018702]
Laboratory literature summary: Conformation of peptides of the secretin-VIP-glucagon family in solution. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang Y et al. (1993). Neuroendocrine peptides (NPY, GRP, VIP, somatostatin) from the brain and stomach of… [PMID: 8101369]
Laboratory literature summary: Neuroendocrine peptides (NPY, GRP, VIP, somatostatin) from the brain and stomach of the alligator. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rostène WH (1984). Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide (VIP) [PMID: 6382440]
Laboratory literature summary: Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Blank MA et al. (1986). Effects of VIP and related peptides and Gila monster venom on genitourinary smooth muscle [PMID: 3816973]
Laboratory literature summary: Effects of VIP and related peptides and Gila monster venom on genitourinary smooth muscle. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J (1985). Evidence for common precursors but differential processing of VIP and PHM in… [PMID: 3840886]
Laboratory literature summary: Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rameshwar P et al. (2002). Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow… [PMID: 12225791]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Karasawa Y et al. (1990). Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart… [PMID: 2272357]
Laboratory literature summary: Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Thakur ML et al. (2000). Imaging tumors in research subjects with Tc-99m-VIP [PMID: 11193855]
Laboratory literature summary: Imaging tumors in research subjects with Tc-99m-VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Suda K et al. (1992). Investigation of the interaction of VIP binding sites with VIP and PACAP in research… [PMID: 1320752]
Laboratory literature summary: Investigation of the interaction of VIP binding sites with VIP and PACAP in research subjects brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Juarranz MG et al. (2001). Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation [PMID: 11398176]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Naruse S et al. (1986). Helodermin has a VIP-like effect upon canine blood flow [PMID: 3748849]
Laboratory literature summary: Helodermin has a VIP-like effect upon canine blood flow. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Smalley SG et al. (2009). Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP):… [PMID: 19604262]
Laboratory literature summary: Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its investigational potential in inflammatory disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Marvaldi J et al. (1986). Characterization of the vasoactive intestinal peptide (VIP) binding sites: a… [PMID: 3018691]
Laboratory literature summary: Characterization of the vasoactive intestinal peptide (VIP) binding sites: a biochemical and an immunological approach. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhou ZC et al. (1989). Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini [PMID: 2465694]
Laboratory literature summary: Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dvoráková MC (2005). Cardioprotective role of the VIP signaling system [PMID: 16341283]
Laboratory literature summary: Cardioprotective role of the VIP signaling system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Malvasi A et al. (2011). Distribution of substance P (SP) and vasoactive intestinal peptide (VIP) in… [PMID: 21167238]
Laboratory literature summary: Distribution of substance P (SP) and vasoactive intestinal peptide (VIP) in pseudocapsules of uterine fibroids. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Moody TW et al. (1998). VIP and breast oncology research models [PMID: 9928023]
Laboratory literature summary: VIP and breast oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pozo D et al. (2004). The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide? [PMID: 15333575]
Laboratory literature summary: The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zimmerman TW et al. (1985). Peptide binding to intestinal epithelium: distinct sites for insulin, EGF and VIP [PMID: 2994023]
Laboratory literature summary: Peptide binding to intestinal epithelium: distinct sites for insulin, EGF and VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1989). Non-amidated forms of VIP (glycine-extended VIP and VIP-free acid) have full… [PMID: 2623188]
Laboratory literature summary: Non-amidated forms of VIP (glycine-extended VIP and VIP-free acid) have full bioactivity on smooth muscle. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Verástegui C et al. (1997). Presence and distribution of 5HT-, VIP-, NPY-, and SP-immunoreactive structures in… [PMID: 9302550]
Laboratory literature summary: Presence and distribution of 5HT-, VIP-, NPY-, and SP-immunoreactive structures in adult mouse lung. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Magistretti PJ et al. (1986). Actions of VIP, hGRF, PHI and secretin: comparative studies in cerebral cortex and… [PMID: 3018695]
Laboratory literature summary: Actions of VIP, hGRF, PHI and secretin: comparative studies in cerebral cortex and adenohypophysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bellan C et al. (1991). Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP… [PMID: 1667418]
Laboratory literature summary: Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP accumulation into two research subjects cancerous cell…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fishbein VA et al. (1994). A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor… [PMID: 7912431]
Laboratory literature summary: A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sanides-Kohlrausch C et al. (1990). VIP- and PHI-immunoreactivity in olfactory centers of the adult cat [PMID: 2341612]
Laboratory literature summary: VIP- and PHI-immunoreactivity in olfactory centers of the adult cat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gozes I et al. (1994). Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for… [PMID: 8156912]
Laboratory literature summary: Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1986). Cosecretion of peptide histidine methionine (PHM) and vasoactive intestinal peptide… [PMID: 3797338]
Laboratory literature summary: Cosecretion of peptide histidine methionine (PHM) and vasoactive intestinal peptide (VIP) in research subjects with VIP-producing tumors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ahrén B et al. (1989). Effects of VIP and helodermin on thyroid hormone secretion in the mouse [PMID: 2922106]
Laboratory literature summary: Effects of VIP and helodermin on thyroid hormone secretion in the mouse. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dufes C et al. (2003). Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration… [PMID: 12672605]
Laboratory literature summary: Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Askar B et al. (2015). Vasoactive intestinal peptide (VIP) differentially affects inflammatory immune… [PMID: 26206287]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) differentially affects inflammatory immune responses in research subjects monocytes infected with…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ekblad E et al. (1985). Two distinct VIP precursors in cartilaginous fish? [PMID: 3913914]
Laboratory literature summary: Two distinct VIP precursors in cartilaginous fish?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fazekas A et al. (1987). VIP and noncholinergic vasodilatation in rabbit submandibular gland [PMID: 2437546]
Laboratory literature summary: VIP and noncholinergic vasodilatation in rabbit submandibular gland. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ito T et al. (2000). Rat and guinea pig pancreatic acini possess both VIP(1) and VIP(2) receptors, which… [PMID: 10644563]
Laboratory literature summary: Rat and guinea pig pancreatic acini possess both VIP(1) and VIP(2) receptors, which mediate enzyme secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schaffalitzky de Muckadell OB et al. (1977). Release of vasoactive intestinal polypeptide (VIP) by intraduodenal stimuli [PMID: 594650]
Laboratory literature summary: Release of vasoactive intestinal polypeptide (VIP) by intraduodenal stimuli. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alexander LD et al. (1995). Involvement of vasopressin and corticotropin-releasing hormone in VIP- and PHI-induced… [PMID: 7791960]
Laboratory literature summary: Involvement of vasopressin and corticotropin-releasing hormone in VIP- and PHI-induced secretion of ACTH and corticosterone. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rosati L et al. (2017). Vasoactive intestinal peptide (VIP) localization in the epididymis of two vertebrate… [PMID: 28784577]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) localization in the epididymis of two vertebrate species. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Konturek SJ et al. (1976). Comparison of vasoactive intestinal peptide (VIP) and secretin in gastric secretion… [PMID: 765958]
Laboratory literature summary: Comparison of vasoactive intestinal peptide (VIP) and secretin in gastric secretion and mucosal blood flow. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Du BH et al. (1985). Guinea pig has a unique mammalian VIP [PMID: 4004849]
Laboratory literature summary: Guinea pig has a unique mammalian VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bjellerup P et al. (1995). Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and… [PMID: 7576950]
Laboratory literature summary: Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lamperti ED et al. (1991). Characterization of the gene and messages for vasoactive intestinal polypeptide (VIP)… [PMID: 1851524]
Laboratory literature summary: Characterization of the gene and messages for vasoactive intestinal polypeptide (VIP) in rat and mouse. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cottrell GA et al. (1984). Behavioral actions of vasoactive intestinal peptide (VIP) [PMID: 6089028]
Laboratory literature summary: Behavioral actions of vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ebeid AM et al. (1977). Release of VIP by calcium stimulation [PMID: 835774]
Laboratory literature summary: Release of VIP by calcium stimulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Korkmaz OT et al. (2021). Vasoactive intestinal peptide (VIP) conducts the neuronal activity during absence… [PMID: 34571088]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) conducts the neuronal activity during absence seizures: GABA seems to be the main mediator of VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kitano H et al. (1998). Presence of mRNA for vasoactive intestinal polypeptide (VIP) and its receptor in the… [PMID: 9682813]
Laboratory literature summary: Presence of mRNA for vasoactive intestinal polypeptide (VIP) and its receptor in the rat inner ear. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
King JT Jr et al. (1988). VIP-, SS-, and GABA-like immunoreactivity in the mid-hippocampal region of El… [PMID: 3214726]
Laboratory literature summary: VIP-, SS-, and GABA-like immunoreactivity in the mid-hippocampal region of El (epileptic) and C57BL/6 mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Conlon JM et al. (1985). Regulatory peptides (glucagon, somatostatin, substance P, and VIP) in the brain and… [PMID: 2580753]
Laboratory literature summary: Regulatory peptides (glucagon, somatostatin, substance P, and VIP) in the brain and gastrointestinal tract of Ambystoma mexicanum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Thakur ML et al. (2004). PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP)… [PMID: 15299065]
Laboratory literature summary: PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Valdehita A et al. (2010). Nuclear localization of vasoactive intestinal peptide (VIP) receptors in research… [PMID: 20691743]
Laboratory literature summary: Nuclear localization of vasoactive intestinal peptide (VIP) receptors in research subjects breast oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ng SY et al. (2012). Agnathan VIP, PACAP and their receptors: ancestral origins of today's highly… [PMID: 22957100]
Laboratory literature summary: Agnathan VIP, PACAP and their receptors: ancestral origins of today's highly diversified forms. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kitanishi T et al. (1998). Immunohistochemical detection of vasoactive intestinal polypeptide (VIP) and the VIP… [PMID: 10095862]
Laboratory literature summary: Immunohistochemical detection of vasoactive intestinal polypeptide (VIP) and the VIP receptor in the rat inner ear. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shima K et al. (1996). Characterization of VIP-and helodermin-preferring receptors on rat platelets [PMID: 8837217]
Laboratory literature summary: Characterization of VIP-and helodermin-preferring receptors on rat platelets. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Studeny S et al. (2008). Urinary bladder function and somatic sensitivity in vasoactive intestinal polypeptide… [PMID: 18561033]
Laboratory literature summary: Urinary bladder function and somatic sensitivity in vasoactive intestinal polypeptide (VIP)-/- mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Reed HE et al. (2001). Vasoactive intestinal polypeptide (VIP) phase-shifts the rat suprachiasmatic nucleus… [PMID: 11207820]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) phase-shifts the rat suprachiasmatic nucleus clock in vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dufes C et al. (2003). Effects of the vasoactive intestinal peptide (VIP) and related peptides on… [PMID: 14593209]
Laboratory literature summary: Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Király A et al. (1997). Influence of [4Cl-D-Phe6,Leu17]VIP on VIP- and central TRH-induced gastric hyperemia [PMID: 9392832]
Laboratory literature summary: Influence of [4Cl-D-Phe6,Leu17]VIP on VIP- and central TRH-induced gastric hyperemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Collado B et al. (2006). Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal… [PMID: 16563610]
Laboratory literature summary: Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Szema AM et al. (2006). Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation,… [PMID: 16782752]
Laboratory literature summary: Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Szabadfi K et al. (2012). Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration [PMID: 22544514]
Laboratory literature summary: Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ventre G et al. (2013). Salivary VIP concentrations are elevated in research subjects after acute stress [PMID: 23994551]
Laboratory literature summary: Salivary VIP concentrations are elevated in research subjects after acute stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dzirasa K (2017). Working memory: The real VIP [PMID: 28490667]
Laboratory literature summary: Working memory: The real VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Calam J et al. (1984). Renal function during vasoactive intestinal peptide (VIP) infusions in normal man and… [PMID: 6382198]
Laboratory literature summary: Renal function during vasoactive intestinal peptide (VIP) infusions in normal man and research subjects with liver disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grundemar L et al. (1992). Unlike VIP, the VIP-related peptides PACAP, helodermin and helospectin suppress… [PMID: 1438978]
Laboratory literature summary: Unlike VIP, the VIP-related peptides PACAP, helodermin and helospectin suppress electrically evoked contractions of rat vas deferens. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sundler F et al. (1978). Peptidergic (VIP) nerves in the pancreas [PMID: 632129]
Laboratory literature summary: Peptidergic (VIP) nerves in the pancreas. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rubinstein I et al. (2005). All D-VIP mitigates vasodilation elicited by L-VIP, micellar L-VIP and micellar… [PMID: 15652658]
Laboratory literature summary: All D-VIP mitigates vasodilation elicited by L-VIP, micellar L-VIP and micellar PACAP1-38, but not PACAP1-38, in vivo. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Eriksson M et al. (1987). Increased levels of vasoactive intestinal peptide (VIP) and oxytocin during suckling… [PMID: 3658810]
Laboratory literature summary: Increased levels of vasoactive intestinal peptide (VIP) and oxytocin during suckling in lactating dogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Guerrero JM et al. (1986). Interaction of a bovine thymic peptide extract with vasoactive intestinal peptide… [PMID: 3021253]
Laboratory literature summary: Interaction of a bovine thymic peptide extract with vasoactive intestinal peptide (VIP) receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frühwald MC et al. (1999). Vasoactive intestinal peptide (VIP) and VIP receptors: gene expression and growth… [PMID: 10188714]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) and VIP receptors: gene expression and growth modulation in medulloblastoma and other central…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Carlquist M et al. (1982). Isolation and amino acid composition of research subjects vasoactive intestinal… [PMID: 7061035]
Laboratory literature summary: Isolation and amino acid composition of research subjects vasoactive intestinal polypeptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Flemström G et al. (1985). Effects of some opiates and vasoactive intestinal peptide (VIP) on duodenal surface… [PMID: 3860926]
Laboratory literature summary: Effects of some opiates and vasoactive intestinal peptide (VIP) on duodenal surface epithelial bicarbonate secretion in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lamanna C et al. (1999). Galanin in the lizard oviduct: its distribution and relationships with… [PMID: 10403497]
Laboratory literature summary: Galanin in the lizard oviduct: its distribution and relationships with estrogen-pathway markers-pathway markers, VIP and oviposition. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grundemar L et al. (1990). Vascular effects of helodermin, helospectin I and helospectin II: a comparison with… [PMID: 2331581]
Laboratory literature summary: Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Xin Z et al. (1997). Effect of vasoactive intestinal peptide (VIP) on cytokine production and expression of… [PMID: 9404731]
Laboratory literature summary: Effect of vasoactive intestinal peptide (VIP) on cytokine production and expression of VIP receptors in thymocyte subsets. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dangoor D et al. (2006). Novel extended and branched N-terminal analogs of VIP [PMID: 16962672]
Laboratory literature summary: Novel extended and branched N-terminal analogs of VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dickinson KE et al. (1986). Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung [PMID: 3025822]
Laboratory literature summary: Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jørgensen JC (1991). Interaction between norepinephrine, NPY and VIP in the ovarian artery [PMID: 1788146]
Laboratory literature summary: Interaction between norepinephrine, NPY and VIP in the ovarian artery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vu JP et al. (2015). Regulation of feeding-behavior endpoints, Body Composition, and Metabolic Hormones by Vasoactive… [PMID: 25904310]
Laboratory literature summary: Regulation of feeding-behavior endpoints, Body Composition, and Metabolic Hormones by Vasoactive Intestinal Polypeptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alexander LD et al. (1995). VIP antagonist demonstrates differences in VIP- and PHI-mediated stimulation and… [PMID: 8577937]
Laboratory literature summary: VIP antagonist demonstrates differences in VIP- and PHI-mediated stimulation and inhibition of ACTH and corticosterone secretion in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Robberecht P et al. (1988). Pharmacological characterization of VIP receptors in research subjects lung membranes [PMID: 2836826]
Laboratory literature summary: Pharmacological characterization of VIP receptors in research subjects lung membranes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nam C et al. (2009). The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation [PMID: 18663606]
Laboratory literature summary: The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI et al. (1980). VIP: Possible functions as a neural peptide [PMID: 6104904]
Laboratory literature summary: VIP: Possible functions as a neural peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Segura JJ et al. (1991). Characterization of functional receptors for vasoactive intestinal peptide (VIP) in… [PMID: 1652777]
Laboratory literature summary: Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
McMaster D et al. (1987). Iodinated derivatives of vasoactive intestinal peptide (VIP), PHI and PHM:… [PMID: 3628082]
Laboratory literature summary: Iodinated derivatives of vasoactive intestinal peptide (VIP), PHI and PHM: purification, chemical characterization and biological activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schaaper WM et al. (1984). Synthesis of vasoactive intestinal peptide (VIP) via the mixed anhydride method [PMID: 6473149]
Laboratory literature summary: Synthesis of vasoactive intestinal peptide (VIP) via the mixed anhydride method. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gafvelin G et al. (1991). A fragment of triosephosphate isomerase competes with the vasoactive intestinal… [PMID: 1851427]
Laboratory literature summary: A fragment of triosephosphate isomerase competes with the vasoactive intestinal polypeptide (VIP) for binding to the VIP receptor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rubinstein I et al. (1999). Conformation and vasoreactivity of VIP in phospholipids: effects of calmodulin [PMID: 10698126]
Laboratory literature summary: Conformation and vasoreactivity of VIP in phospholipids: effects of calmodulin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Blitz W et al. (1985). Cholinergic and pancreatic actions of purified porcine and synthetic vasoactive… [PMID: 4062433]
Laboratory literature summary: Cholinergic and pancreatic actions of purified porcine and synthetic vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ohmori Y et al. (2004). Pharmacological effects and lung-binding characteristics of a novel VIP analogue,… [PMID: 15518913]
Laboratory literature summary: Pharmacological effects and lung-binding characteristics of a novel VIP analogue, [R15, 20, 21, L17]-VIP-GRR (IK312532). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kim MJ et al. (2003). Vasoactive intestinal peptide (VIP) and VIP mRNA decrease in the cerebral cortex of… [PMID: 12834919]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) and VIP mRNA decrease in the cerebral cortex of nNOS knock-out(-/-) mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zane HK et al. (2017). Versatile Interacting Peptide (VIP) Tags for Labeling Proteins with Bright Chemical… [PMID: 28052473]
Laboratory literature summary: Versatile Interacting Peptide (VIP) Tags for Labeling Proteins with Bright Chemical Reporters. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Robberecht P et al. (1986). Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP… [PMID: 3017717]
Laboratory literature summary: Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dangoor D et al. (2007). Novel analogs of VIP with multiple C-terminal domains [PMID: 17481779]
Laboratory literature summary: Novel analogs of VIP with multiple C-terminal domains. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dimaline R et al. (1986). Purification and characterisation of VIP from two species of dogfish [PMID: 3748847]
Laboratory literature summary: Purification and characterisation of VIP from two species of dogfish. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Calvo JR et al. (1986). Interaction of thymic peptide thymosin alpha 1 with vasoactive intestinal peptide… [PMID: 3028522]
Laboratory literature summary: Interaction of thymic peptide thymosin alpha 1 with vasoactive intestinal peptide (VIP) receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Henriksen JH et al. (1980). Vasoactive intestinal polypeptide (VIP) in cirrhosis: arteriovenous extraction in… [PMID: 7209387]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) in cirrhosis: arteriovenous extraction in different vascular beds. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Calvo JJ et al. (1990). Effect of ACTH on VIP and galanin release from the pituitary [PMID: 1688792]
Laboratory literature summary: Effect of ACTH on VIP and galanin release from the pituitary. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gourlet P et al. (1998). Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP… [PMID: 9726637]
Laboratory literature summary: Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gespach C et al. (1988). Pharmacology and molecular identification of vasoactive intestinal peptide (VIP)… [PMID: 2831906]
Laboratory literature summary: Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Turner JT et al. (1986). A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in… [PMID: 3025826]
Laboratory literature summary: A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dufes C et al. (2004). Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain [PMID: 15488681]
Laboratory literature summary: Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Caraglia M et al. (2006). Effects of VIP and VIP-DAP on proliferation and lipid peroxidation metabolism in… [PMID: 16888160]
Laboratory literature summary: Effects of VIP and VIP-DAP on proliferation and lipid peroxidation metabolism in research subjects KB cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Holle GE et al. (1995). Effect of 17-norleucine-VIP on gastroduodenal motility relative to serum VIP… [PMID: 7485511]
Laboratory literature summary: Effect of 17-norleucine-VIP on gastroduodenal motility relative to serum VIP concentration and blockade of NOS. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Köves K et al. (2002). PACAP and VIP in the photoneuroendocrine system (PNES) [PMID: 11862161]
Laboratory literature summary: PACAP and VIP in the photoneuroendocrine system (PNES). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dimaline R et al. (1986). Isolation and partial sequence of elasmobranch VIP [PMID: 3715063]
Laboratory literature summary: Isolation and partial sequence of elasmobranch VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bhargava S et al. (2002). A complete substitutional analysis of VIP for better oncology research models imaging… [PMID: 12203840]
Laboratory literature summary: A complete substitutional analysis of VIP for better oncology research models imaging properties. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ottesen B et al. (1984). Vasoactive intestinal peptide (VIP) stimulates oxytocin and vasopressin release from… [PMID: 6479104]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) stimulates oxytocin and vasopressin release from the neurohypophyis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Laburthe M et al. (1986). Study of species specificity in growth hormone-releasing factor (GRF) interaction with… [PMID: 3003561]
Laboratory literature summary: Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Theriault E et al. (1987). Morphology of striatal neurons containing VIP-like immunoreactivity [PMID: 2434535]
Laboratory literature summary: Morphology of striatal neurons containing VIP-like immunoreactivity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wulff B et al. (1997). The C-terminal part of VIP is important for receptor binding and activation, as… [PMID: 9303545]
Laboratory literature summary: The C-terminal part of VIP is important for receptor binding and activation, as evidenced by chimeric constructs of VIP/secretin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Luis J et al. (1990). Characterization of VIP- and helodermin-preferring receptors on research subjects… [PMID: 1965034]
Laboratory literature summary: Characterization of VIP- and helodermin-preferring receptors on research subjects small cell lung carcinoma cell lines. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Toscano MG et al. (2010). Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into… [PMID: 20068554]
Laboratory literature summary: Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Weick RF et al. (1992). Effect of [4Cl-D-Phe6,Leu17]VIP on the inhibition of pulsatile LH release by VIP and… [PMID: 1488097]
Laboratory literature summary: Effect of [4Cl-D-Phe6,Leu17]VIP on the inhibition of pulsatile LH release by VIP and related peptides in the ovariectomized rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nilsson SF et al. (1984). Vasoactive intestinal polypeptide (VIP): effects in the eye and on regional blood flows [PMID: 6148840]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP): effects in the eye and on regional blood flows. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kaku K et al. (1986). Circadian cycles in VIP content and VIP stimulation of cyclic AMP accumulation in the… [PMID: 3018698]
Laboratory literature summary: Circadian cycles in VIP content and VIP stimulation of cyclic AMP accumulation in the rat pineal gland. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shirai M et al. (1990). Content and distribution of vasoactive intestinal polypeptide (VIP) in cavernous… [PMID: 2321332]
Laboratory literature summary: Content and distribution of vasoactive intestinal polypeptide (VIP) in cavernous tissue of research subjects penis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gonzalez-Rey E et al. (2006). VIP: an agent with license to kill infective parasites [PMID: 16888182]
Laboratory literature summary: VIP: an agent with license to kill infective parasites. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bondesson L et al. (1991). Dual effects of vasoactive intestinal peptide (VIP) on leucocyte migration [PMID: 1877347]
Laboratory literature summary: Dual effects of vasoactive intestinal peptide (VIP) on leucocyte migration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ahmed CE et al. (1986). The immature rat ovary is innervated by vasoactive intestinal peptide (VIP)-containing… [PMID: 3512260]
Laboratory literature summary: The immature rat ovary is innervated by vasoactive intestinal peptide (VIP)-containing fibers and responds to VIP with steroid secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lundberg P et al. (2001). Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide… [PMID: 11145597]
Laboratory literature summary: Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts:…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gaudin P et al. (1995). Mutational analysis of cysteine residues within the extracellular domains of the… [PMID: 7598720]
Laboratory literature summary: Mutational analysis of cysteine residues within the extracellular domains of the research subjects vasoactive intestinal peptide (VIP) 1…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Robichon A et al. (1987). Selective photolabeling of high and low affinity binding sites for vasoactive… [PMID: 3026793]
Laboratory literature summary: Selective photolabeling of high and low affinity binding sites for vasoactive intestinal peptide (VIP): evidence for two classes of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lundberg JM et al. (1982). Vascular effects of the peptides PYY and PHI: comparison with APP and VIP [PMID: 6897040]
Laboratory literature summary: Vascular effects of the peptides PYY and PHI: comparison with APP and VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bellinger DL et al. (1997). Vasoactive intestinal polypeptide (VIP) innervation of rat spleen, thymus, and lymph nodes [PMID: 9396054]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) innervation of rat spleen, thymus, and lymph nodes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cheng D et al. (2006). Radiolabeling and in vitro and in vivo characterization of [18F]FB-[R(8,15,21),… [PMID: 17177894]
Laboratory literature summary: Radiolabeling and in vitro and in vivo characterization of [18F]FB-[R(8,15,21), L17]-VIP as a PET imaging agent for oncology research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Morice A et al. (1984). VIP as bronchodilator [PMID: 6142190]
Laboratory literature summary: VIP as bronchodilator. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Troc P et al. (1988). [VIP: laboratory value] [PMID: 3255222]
Laboratory literature summary: [VIP: laboratory value]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Díaz-Juárez JL et al. (1994). VIP suppression in the intestine and cerebral cortex following administration of VIP… [PMID: 7800913]
Laboratory literature summary: VIP suppression in the intestine and cerebral cortex following administration of VIP antiserum to newborn rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vertongen P et al. (1997). Autoradiographic visualization of the receptor subclasses for vasoactive intestinal… [PMID: 9437715]
Laboratory literature summary: Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1979). Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome [PMID: 229653]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1974). Candidate hormones of the gut. V. Vasoactive intestinal peptide (VIP) [PMID: 4606296]
Laboratory literature summary: Candidate hormones of the gut. V. Vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sahir N et al. (2006). Neonatal mice of the Down syndrome model, Ts65Dn, exhibit upregulated VIP measures and… [PMID: 17401158]
Laboratory literature summary: Neonatal mice of the Down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Suzuki Y et al. (1984). Characterization of the relaxant effects of vasoactive intestinal peptide (VIP) and… [PMID: 6549149]
Laboratory literature summary: Characterization of the relaxant effects of vasoactive intestinal peptide (VIP) and PHI on isolated brain arteries. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gozes I et al. (1984). Studies toward the biosynthesis of vasoactive intestinal peptide (VIP) [PMID: 6473148]
Laboratory literature summary: Studies toward the biosynthesis of vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dimaline R et al. (1987). A novel vasoactive intestinal peptide (VIP) from elasmobranch intestine has full… [PMID: 2441759]
Laboratory literature summary: A novel vasoactive intestinal peptide (VIP) from elasmobranch intestine has full affinity for mammalian pancreatic VIP receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Robberecht P et al. (1987). [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective… [PMID: 3036504]
Laboratory literature summary: [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ichiki Y et al. (1992). Organ distribution and characterization of porcine peptides (VIP, CGRP and PHI) that… [PMID: 1329741]
Laboratory literature summary: Organ distribution and characterization of porcine peptides (VIP, CGRP and PHI) that increase cAMP in rat platelets. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hakoda H et al. (1990). Modulation of cholinergic neurotransmission by the peptide VIP, VIP antiserum and VIP… [PMID: 2172520]
Laboratory literature summary: Modulation of cholinergic neurotransmission by the peptide VIP, VIP antiserum and VIP antagonists in dog and cat trachea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grider JR et al. (1990). Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the… [PMID: 2110976]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu YC et al. (1999). Neuroregulation by vasoactive intestinal peptide (VIP) of mucus secretion in ferret… [PMID: 10051131]
Laboratory literature summary: Neuroregulation by vasoactive intestinal peptide (VIP) of mucus secretion in ferret trachea: activation of BK(Ca) channels and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Huang M et al. (1990). PHI preferentially binds to VIP receptors in normal rat tissues [PMID: 2178244]
Laboratory literature summary: PHI preferentially binds to VIP receptors in normal rat tissues. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zawilska JB et al. (2005). Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP… [PMID: 15800375]
Laboratory literature summary: Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Martin JM et al. (1989). A research subjects melanoma-derived cell line (IGR39) with a very high number of… [PMID: 2538331]
Laboratory literature summary: A research subjects melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2.…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Onyüksel H et al. (2003). Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity [PMID: 12668213]
Laboratory literature summary: Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Uehara S et al. (1987). Fundamental and laboratory evaluation of vasoactive intestinal peptide (VIP) in… [PMID: 3317528]
Laboratory literature summary: Fundamental and laboratory evaluation of vasoactive intestinal peptide (VIP) in pancreatitis by radioimmunoassay kit. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zimmerman RP et al. (1988). Vasoactive intestinal peptide (VIP) receptors in the canine gastrointestinal tract [PMID: 2854625]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) receptors in the canine gastrointestinal tract. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sirianni MC et al. (1992). Modulation of research subjects natural killer activity by vasoactive intestinal… [PMID: 1574603]
Laboratory literature summary: Modulation of research subjects natural killer activity by vasoactive intestinal peptide (VIP) family. VIP, glucagon and GHRF…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zia H et al. (1996). Breast oncology research models growth is inhibited by vasoactive intestinal peptide… [PMID: 8758916]
Laboratory literature summary: Breast oncology research models growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Field M et al. (1983). Pancreatic cholera: is the diarrhea due to VIP? [PMID: 6316137]
Laboratory literature summary: Pancreatic cholera: is the diarrhea due to VIP?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Carretero J et al. (1996). Dopamine inhibits in vitro release of VIP and proliferation of VIP-immunoreactive… [PMID: 8868304]
Laboratory literature summary: Dopamine inhibits in vitro release of VIP and proliferation of VIP-immunoreactive pituitary cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Villar HV et al. (1976). Suppression of gastrin release and gastric secretion by gastric inhibitory polypeptide… [PMID: 938120]
Laboratory literature summary: Suppression of gastrin release and gastric secretion by gastric inhibitory polypeptide (GIP) and vasoactive intestinal polypeptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Reale V et al. (1987). Vasoactive intestinal peptide (VIP) induces a K+ current in the Xenopus oocyte membrane [PMID: 2450310]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) induces a K+ current in the Xenopus oocyte membrane. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kidane AH et al. (2007). Actions of PACAP and VIP on melanotrope cells of Xenopus laevis [PMID: 17482316]
Laboratory literature summary: Actions of PACAP and VIP on melanotrope cells of Xenopus laevis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Robberecht P et al. (1990). Heterogeneity of VIP receptors [PMID: 2164799]
Laboratory literature summary: Heterogeneity of VIP receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hvidsten D et al. (1989). Clearance of vasoactive intestinal polypeptide (VIP) in the porcine pulmonary circulation [PMID: 2623191]
Laboratory literature summary: Clearance of vasoactive intestinal polypeptide (VIP) in the porcine pulmonary circulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Eriksson LS et al. (1989). Influence of vasoactive intestinal polypeptide (VIP) on splanchnic and central… [PMID: 2666962]
Laboratory literature summary: Influence of vasoactive intestinal polypeptide (VIP) on splanchnic and central hemodynamics in healthy subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Konturek SJ et al. (1976). Cyclic AMP and bicarbonate responses of the dog pancreas to vasoactive intestinal… [PMID: 184219]
Laboratory literature summary: Cyclic AMP and bicarbonate responses of the dog pancreas to vasoactive intestinal peptide (VIP) and secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pozo D et al. (1995). Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat… [PMID: 7784261]
Laboratory literature summary: Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat peritoneal macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Calvo JR et al. (1986). Interaction of vasoactive intestinal peptide (VIP) with rat lymphoid cells [PMID: 3016677]
Laboratory literature summary: Interaction of vasoactive intestinal peptide (VIP) with rat lymphoid cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Haidan A et al. (1998). Research subjects adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic… [PMID: 9864057]
Laboratory literature summary: research subjects adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic effect of vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mao YK et al. (1993). VIP receptors on canine submucosal synaptosomes [PMID: 8134296]
Laboratory literature summary: VIP receptors on canine submucosal synaptosomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ikezaki H et al. (1998). Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster… [PMID: 9688960]
Laboratory literature summary: Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tan YV et al. (2004). Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further… [PMID: 15247290]
Laboratory literature summary: Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further insights into the interaction of VIP with the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Todorovic V et al. (1996). Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis–a… [PMID: 8799381]
Laboratory literature summary: Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis–a radioimmunoassay and immunohistochemical study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rostene WH et al. (1983). Modulation by vasoactive intestinal peptide (VIP) of serotonin receptors in membranes… [PMID: 6655494]
Laboratory literature summary: Modulation by vasoactive intestinal peptide (VIP) of serotonin receptors in membranes from rat hippocampus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lundberg JM et al. (1981). Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for… [PMID: 7345898]
Laboratory literature summary: Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. I.…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tanaka Y et al. (1995). Precise localization of VIP-, NPY-, and TH-immunoreactivities of cat laryngeal glands [PMID: 7697374]
Laboratory literature summary: Precise localization of VIP-, NPY-, and TH-immunoreactivities of cat laryngeal glands. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Taton G et al. (1981). Characterization of the VIP- and secretin-stimulated adenylate cyclase system from… [PMID: 6126856]
Laboratory literature summary: Characterization of the VIP- and secretin-stimulated adenylate cyclase system from research subjects lung. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sena M et al. (1994). High conservation of upstream regulatory sequences on the research subjects and mouse… [PMID: 7894056]
Laboratory literature summary: High conservation of upstream regulatory sequences on the research subjects and mouse vasoactive intestinal peptide (VIP) genes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Muller JM et al. (1989). Functional vasoactive intestinal polypeptide (VIP) receptors in research subjects… [PMID: 2537287]
Laboratory literature summary: Functional vasoactive intestinal polypeptide (VIP) receptors in research subjects neuroblastoma subclones that contain VIP precursor…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang SC et al. (1985). Purification of dog VIP from a single animal [PMID: 4033346]
Laboratory literature summary: Purification of dog VIP from a single animal. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ottesen B et al. (1986). Effect of vasoactive intestinal polypeptide (VIP) on steroidogenesis in research subjects [PMID: 3562902]
Laboratory literature summary: Effect of vasoactive intestinal polypeptide (VIP) on steroidogenesis in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ahrén B (1984). Influence of VIP on thyroid hormone secretion [PMID: 6473158]
Laboratory literature summary: Influence of VIP on thyroid hormone secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Andersson M et al. (1991). The preparation of biotinyl-epsilon-aminocaproylated forms of the vasoactive… [PMID: 1851109]
Laboratory literature summary: The preparation of biotinyl-epsilon-aminocaproylated forms of the vasoactive intestinal polypeptide (VIP) as probes for the VIP receptor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ottavi A et al. (1998). An improved method to obtain a single recombinant vasoactive intestinal peptide (VIP)… [PMID: 9672747]
Laboratory literature summary: An improved method to obtain a single recombinant vasoactive intestinal peptide (VIP) analog. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Leboulenger F et al. (1983). Co-localization of vasoactive intestinal peptide (VIP) and enkephalins in chromaffin… [PMID: 6131369]
Laboratory literature summary: Co-localization of vasoactive intestinal peptide (VIP) and enkephalins in chromaffin cells of the adrenal gland of amphibia. Stimulation…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mikkelsen JD (1989). Immunohistochemical localization of vasoactive intestinal peptide (VIP) in the… [PMID: 2924334]
Laboratory literature summary: Immunohistochemical localization of vasoactive intestinal peptide (VIP) in the circumventricular organs of the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sims KB et al. (1980). Vasoactive intestinal polypeptide (VIP) in mouse and rat brain: an immunocytochemical… [PMID: 6986955]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) in mouse and rat brain: an immunocytochemical study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1994). VIP and messenger plasticity [PMID: 7526504]
Laboratory literature summary: VIP and messenger plasticity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fernandez-Moreno MD et al. (1987). Ileal vasoactive intestinal peptide (VIP) levels and VIP receptor/effector system in… [PMID: 2823853]
Laboratory literature summary: Ileal vasoactive intestinal peptide (VIP) levels and VIP receptor/effector system in ileal epithelial cells after colectomy in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wiik P et al. (1988). Receptors for vasoactive intestinal peptide (VIP) on research subjects mononuclear… [PMID: 2834700]
Laboratory literature summary: Receptors for vasoactive intestinal peptide (VIP) on research subjects mononuclear leucocytes are upregulated during prolonged strain…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mazzocchi G et al. (1994). Stimulatory effect of vasoactive intestinal peptide (VIP) on the secretory activity of… [PMID: 8180111]
Laboratory literature summary: Stimulatory effect of vasoactive intestinal peptide (VIP) on the secretory activity of dispersed rat adrenocortical cells. Evidence for…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ichinose M et al. (1994). Inhibitory effect of vasoactive intestinal peptide (VIP) on phagocytosis in mouse… [PMID: 7536335]
Laboratory literature summary: Inhibitory effect of vasoactive intestinal peptide (VIP) on phagocytosis in mouse peritoneal macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wharton J et al. (1980). Enkephalin-, VIP- and substance P-like immunoreactivity in the carotid body [PMID: 6153760]
Laboratory literature summary: Enkephalin-, VIP- and substance P-like immunoreactivity in the carotid body. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Leys K et al. (1986). Autoradiographic localisation of VIP receptors in research subjects lung [PMID: 3009219]
Laboratory literature summary: Autoradiographic localisation of VIP receptors in research subjects lung. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mao YK et al. (1991). Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and… [PMID: 1653848]
Laboratory literature summary: Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hansen V et al. (1988). Effects of VIP and PHM in research subjects intracervical arteries [PMID: 3250182]
Laboratory literature summary: Effects of VIP and PHM in research subjects intracervical arteries. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vaisrub S (1975). Editorial: VIP and WDHA [PMID: 171461]
Laboratory literature summary: Editorial: VIP and WDHA. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Houtz J et al. (2014). VIP pipes up: neuronal signals direct tubulogenesis [PMID: 25158849]
Laboratory literature summary: VIP pipes up: neuronal signals direct tubulogenesis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lundberg JM et al. (1981). Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for… [PMID: 7345899]
Laboratory literature summary: Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion.…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Day R et al. (1983). Asbestos-related increase in pulmonary levels of vasoactive intestinal peptide (VIP) [PMID: 6196589]
Laboratory literature summary: Asbestos-related increase in pulmonary levels of vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yamaguchi K et al. (1995). [Vasoactive intestinal polypeptide (VIP)] [PMID: 8753319]
Laboratory literature summary: [Vasoactive intestinal polypeptide (VIP)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ottesen B et al. (1987). Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal… [PMID: 3432128]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bolin DR et al. (1993). Structure-activity studies of vasoactive intestinal peptide (VIP): cyclic disulfide… [PMID: 8384606]
Laboratory literature summary: Structure-activity studies of vasoactive intestinal peptide (VIP): cyclic disulfide analogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhang M et al. (2000). Vasoactive intestinal peptide (VIP) exacerbates endotoxin-induced uveitis (EIU) in mice [PMID: 11262614]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) exacerbates endotoxin-induced uveitis (EIU) in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Laburthe M et al. (1977). Vasoactive intestinal peptide (VIP): variation of the jejuno-ileal content in the… [PMID: 576532]
Laboratory literature summary: Vasoactive intestinal peptide (VIP): variation of the jejuno-ileal content in the developing rat as measured by radioreceptorassay. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nguyen TD (1988). Peptide T from research subjects immunodeficiency virus envelope does not interact… [PMID: 2836827]
Laboratory literature summary: Peptide T from research subjects immunodeficiency virus envelope does not interact with hepatic, intestinal and colonic vasoactive…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Woltering EA et al. (1986). The response of a non-functional VIP- and somatostatin-containing oncology research… [PMID: 2876496]
Laboratory literature summary: The response of a non-functional VIP- and somatostatin-containing oncology research models to tolbutamide in vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Woie L et al. (1986). Increase in plasma vasoactive intestinal polypeptide (VIP) in muscular exercise in… [PMID: 3721187]
Laboratory literature summary: Increase in plasma vasoactive intestinal polypeptide (VIP) in muscular exercise in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Takashima A et al. (1993). Vasoactive intestinal peptide (VIP) causes memory impairment in passive avoidance… [PMID: 8284258]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) causes memory impairment in passive avoidance responding of the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ashur-Fabian O et al. (1999). SNV, a lipophilic superactive VIP analog, acts through cGMP to promote neuronal survival [PMID: 10465516]
Laboratory literature summary: SNV, a lipophilic superactive VIP analog, acts through cGMP to promote neuronal survival. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gall C et al. (1986). Distribution of VIP- and NPY-like immunoreactivities in rat main olfactory bulb [PMID: 2424562]
Laboratory literature summary: Distribution of VIP- and NPY-like immunoreactivities in rat main olfactory bulb. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Crimi N et al. (1988). Effect of vasoactive intestinal peptide (VIP) on propranolol-induced bronchoconstriction [PMID: 2971708]
Laboratory literature summary: Effect of vasoactive intestinal peptide (VIP) on propranolol-induced bronchoconstriction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brook CW et al. (1988). Hepatic metabolism of vasoactive intestinal polypeptide (VIP) in the rat [PMID: 3368582]
Laboratory literature summary: Hepatic metabolism of vasoactive intestinal polypeptide (VIP) in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mandel KG et al. (1986). Ba2+ inhibition of VIP- and A23187-stimulated Cl- secretion by T84 cell monolayers [PMID: 2420200]
Laboratory literature summary: Ba2+ inhibition of VIP- and A23187-stimulated Cl- secretion by T84 cell monolayers. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brenneman DE et al. (1985). Neurotrophic action of VIP on spinal cord cultures [PMID: 4080617]
Laboratory literature summary: Neurotrophic action of VIP on spinal cord cultures. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grider JR et al. (1992). Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP… [PMID: 1566853]
Laboratory literature summary: Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jansson R et al. (1978). Effects of intravenous vasoactive intestinal peptide (VIP) on gallbladder function in… [PMID: 401095]
Laboratory literature summary: Effects of intravenous vasoactive intestinal peptide (VIP) on gallbladder function in the cat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Drucker-Colín R et al. (1984). Is vasoactive intestinal polypeptide (VIP) a sleep factor? [PMID: 6494029]
Laboratory literature summary: Is vasoactive intestinal polypeptide (VIP) a sleep factor?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Carmena MJ et al. (1987). Effect of gastroduodenostomy on intestinal vasoactive intestinal peptide (VIP) levels,… [PMID: 2440464]
Laboratory literature summary: Effect of gastroduodenostomy on intestinal vasoactive intestinal peptide (VIP) levels, and VIP binding and VIP stimulation of cyclic AMP…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Quik M et al. (1978). Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation… [PMID: 83146]
Laboratory literature summary: Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yaksh TL et al. (1987). Cortical vasodilatation produced by vasoactive intestinal polypeptide (VIP) and by… [PMID: 3108270]
Laboratory literature summary: Cortical vasodilatation produced by vasoactive intestinal polypeptide (VIP) and by physiological stimuli in the cat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lundberg JM et al. (1979). Substance P-, VIP-, and enkephalin-like immunoreactivity in the research subjects… [PMID: 378753]
Laboratory literature summary: Substance P-, VIP-, and enkephalin-like immunoreactivity in the research subjects vagus nerve. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ohta T et al. (1991). Effects of vasoactive intestinal peptide (VIP) on contractile responses of smooth… [PMID: 1364828]
Laboratory literature summary: Effects of vasoactive intestinal peptide (VIP) on contractile responses of smooth muscle in rat stomach. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pelletier G et al. (1981). Electron immunocytochemistry in vasoactive intestinal peptide (VIP) in the rat brain [PMID: 7013904]
Laboratory literature summary: Electron immunocytochemistry in vasoactive intestinal peptide (VIP) in the rat brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gafvelin G (1990). Isolation and primary structure of VIP from sheep brain [PMID: 2235680]
Laboratory literature summary: Isolation and primary structure of VIP from sheep brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Falsetti L et al. (1988). Vasoactive intestinal polypeptide (VIP) selectively stimulates prolactin release in… [PMID: 3140588]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) selectively stimulates prolactin release in healthy research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Csillag A et al. (1993). Matching localization of vasoactive intestinal polypeptide (VIP) and VIP-receptor at… [PMID: 8393920]
Laboratory literature summary: Matching localization of vasoactive intestinal polypeptide (VIP) and VIP-receptor at pre- and postsynaptic sites in the mouse visual cortex. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Morris JL et al. (1989). Porcine VIP is more potent than guinea pig VIP in relaxing the guinea pig uterine artery [PMID: 2587428]
Laboratory literature summary: Porcine VIP is more potent than guinea pig VIP in relaxing the guinea pig uterine artery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Leboulenger F et al. (1984). Action of vasoactive intestinal peptide (VIP) on amphibian adrenocortical function, in… [PMID: 6473157]
Laboratory literature summary: Action of vasoactive intestinal peptide (VIP) on amphibian adrenocortical function, in vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Watanabe S (2005). [Vasoactive intestinal polypeptide (VIP)] [PMID: 16149562]
Laboratory literature summary: [Vasoactive intestinal polypeptide (VIP)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Woodward RM et al. (1987). Membrane currents elicited by porcine vasoactive intestinal peptide (VIP) in… [PMID: 2447588]
Laboratory literature summary: Membrane currents elicited by porcine vasoactive intestinal peptide (VIP) in follicle-enclosed Xenopus oocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ahrén B et al. (1981). Effects of vasoactive intestinal polypeptide (VIP), secretin and gastrin on insulin… [PMID: 7009286]
Laboratory literature summary: Effects of vasoactive intestinal polypeptide (VIP), secretin and gastrin on insulin secretion in the mouse. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yang S (1991). [Vasoactive intestinal peptide (VIP) concentration in ischemic rat brain microvessels] [PMID: 1831732]
Laboratory literature summary: [Vasoactive intestinal peptide (VIP) concentration in ischemic rat brain microvessels]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gozes I et al. (1998). Protection against developmental deficiencies by a lipophilic VIP analogue [PMID: 9566607]
Laboratory literature summary: Protection against developmental deficiencies by a lipophilic VIP analogue. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nagata S et al. (1992). RDC1 may not be VIP receptor [PMID: 1315461]
Laboratory literature summary: RDC1 may not be VIP receptor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hellstrand P et al. (1985). Role of vasoactive intestinal polypeptide (VIP) in the neurogenic vasodilatation of… [PMID: 3911302]
Laboratory literature summary: Role of vasoactive intestinal polypeptide (VIP) in the neurogenic vasodilatation of the portal vein in the rabbit. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hamidi SA et al. (2006). Clues to VIP function from knockout mice [PMID: 16888146]
Laboratory literature summary: Clues to VIP function from knockout mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lundberg JM et al. (1981). Characteristics of the axonal transport of vasoactive intestinal polypeptide (VIP) in… [PMID: 7315423]
Laboratory literature summary: Characteristics of the axonal transport of vasoactive intestinal polypeptide (VIP) in nerves of the cat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Moore TC et al. (1988). Depression of lymphocyte traffic in sheep by vasoactive intestinal peptide (VIP) [PMID: 3410493]
Laboratory literature summary: Depression of lymphocyte traffic in sheep by vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Samejima M et al. (1993). Identification of vasoactive intestinal polypeptide (VIP) binding protein in bovine… [PMID: 8513286]
Laboratory literature summary: Identification of vasoactive intestinal polypeptide (VIP) binding protein in bovine pineal gland. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Larsen JJ et al. (1981). Vasoactive intestinal polypeptide (VIP) in the research models genitourinary tract:… [PMID: 7298295]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) in the research models genitourinary tract: concentration and motor effect. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (1975). Editorial: VIP and watery diarrhoea [PMID: 1174913]
Laboratory literature summary: Editorial: VIP and watery diarrhoea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Willis EA et al. (1983). Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection [PMID: 6410140]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dalcik H et al. (1993). Median eminence-afferent vasoactive intestinal peptide (VIP) neurons in the… [PMID: 8284257]
Laboratory literature summary: Median eminence-afferent vasoactive intestinal peptide (VIP) neurons in the hypothalamus: localization by simultaneous tract tracing and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kataoka K (1978). [Recent findings on neural VIP] [PMID: 416249]
Laboratory literature summary: [Recent findings on neural VIP]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (1975). Letter: Pancreatic cholera and vip [PMID: 1160944]
Laboratory literature summary: Letter: Pancreatic cholera and vip. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Iwanaga T (2002). [Vasoactive intestinal polypeptide (VIP)] [PMID: 12166175]
Laboratory literature summary: [Vasoactive intestinal polypeptide (VIP)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Watanabe S (1999). [Vasoactive intestinal polypeptide (VIP)] [PMID: 10778131]
Laboratory literature summary: [Vasoactive intestinal polypeptide (VIP)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lissbrant E et al. (1997). Effects of vasoactive intestinal peptide (VIP) on the testicular vasculature of the rat [PMID: 9568528]
Laboratory literature summary: Effects of vasoactive intestinal peptide (VIP) on the testicular vasculature of the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Seifert P et al. (1999). Vasoactive intestinal polypeptide (VIP) innervation of the research subjects eyelid glands [PMID: 10375432]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) innervation of the research subjects eyelid glands. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Uddman R et al. (1978). Peptidergic (VIP) innervation of the esophagus [PMID: 401096]
Laboratory literature summary: Peptidergic (VIP) innervation of the esophagus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fernández-Moreno MD et al. (1989). The effects of experimental uremia in rats on duodenal VIP levels and the interaction… [PMID: 2548635]
Laboratory literature summary: The effects of experimental uremia in rats on duodenal VIP levels and the interaction of VIP with duodenal epithelial cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Miyata A et al. (2010). The 9th International Symposium on VIP, PACAP, and Related Peptides [PMID: 20535644]
Laboratory literature summary: The 9th International Symposium on VIP, PACAP, and Related Peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Markos F et al. (2001). The potentiation of sinus arrhythmia by vasoactive intestinal polypeptide (VIP) in the… [PMID: 12030808]
Laboratory literature summary: The potentiation of sinus arrhythmia by vasoactive intestinal polypeptide (VIP) in the anaesthetized dog. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ahrén B et al. (1982). Interaction of vasoactive intestinal peptide (VIP) with cholinergic stimulation of… [PMID: 7042382]
Laboratory literature summary: Interaction of vasoactive intestinal peptide (VIP) with cholinergic stimulation of glucagon secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Karlsson JA et al. (1984). Neither vasoactive intestinal peptide (VIP) nor purine derivatives may mediate… [PMID: 6098141]
Laboratory literature summary: Neither vasoactive intestinal peptide (VIP) nor purine derivatives may mediate non-adrenergic tracheal inhibition. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bozou JC et al. (1987). Phorbol ester induces loss of VIP stimulation of adenylate cyclase and VIP-binding… [PMID: 3026847]
Laboratory literature summary: Phorbol ester induces loss of VIP stimulation of adenylate cyclase and VIP-binding sites in HT29 cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wasowicz K et al. (2001). Influence of active immunization against GnRH on VIP- and NPY-positive innervation of… [PMID: 11534784]
Laboratory literature summary: Influence of active immunization against GnRH on VIP- and NPY-positive innervation of the porcine testis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cormio L et al. (2005). Vasoactive intestinal polypeptide (VIP) is not an androgen-dependent neuromediator of… [PMID: 15526009]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) is not an androgen-dependent neuromediator of penile erection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ito Y et al. (1990). Modulation of cholinergic neurotransmission by VIP, VIP-antiserum and VIP-antagonists… [PMID: 1964363]
Laboratory literature summary: Modulation of cholinergic neurotransmission by VIP, VIP-antiserum and VIP-antagonists in dog and cat trachea: VIP plays a role of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ottesen B et al. (1986). Release of vasoactive intestinal polypeptide (VIP) in breast-feeding research subjects [PMID: 3770283]
Laboratory literature summary: Release of vasoactive intestinal polypeptide (VIP) in breast-feeding research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gomariz RP et al. (1992). Occurrence of vasoactive intestinal peptide (VIP) in lymphoid organs from rat and mouse [PMID: 1605471]
Laboratory literature summary: Occurrence of vasoactive intestinal peptide (VIP) in lymphoid organs from rat and mouse. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Edvinsson L et al. (1984). Distribution and dilatory effect of vasoactive intestinal polypeptide (VIP) in… [PMID: 6382196]
Laboratory literature summary: Distribution and dilatory effect of vasoactive intestinal polypeptide (VIP) in research subjects cerebral arteries. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kniaz D et al. (1991). High-affinity binding sites for VIP in renal cortical membranes: possible role of VIP… [PMID: 1848330]
Laboratory literature summary: High-affinity binding sites for VIP in renal cortical membranes: possible role of VIP in renal transport. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kameda Y (1989). Distribution of CGRP-, somatostatin-, galanin-, VIP-, and substance P-immunoreactive… [PMID: 2477154]
Laboratory literature summary: Distribution of CGRP-, somatostatin-, galanin-, VIP-, and substance P-immunoreactive nerve fibers in the chicken carotid body. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bodanszky M et al. (1977). Synthesis and pharmacological properties of the N-terminal decapeptide of the… [PMID: 915906]
Laboratory literature summary: Synthesis and pharmacological properties of the N-terminal decapeptide of the vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Galbo H et al. (1979). Fasting and prolonged exercise increase vasoactive intestinal polypeptide (VIP) in plasma [PMID: 443066]
Laboratory literature summary: Fasting and prolonged exercise increase vasoactive intestinal polypeptide (VIP) in plasma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Longshore MA et al. (1981). Stimulation of retinal adenylate cyclase by vasoactive intestinal peptide (VIP) [PMID: 7262187]
Laboratory literature summary: Stimulation of retinal adenylate cyclase by vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Beyer C et al. (1991). Vasoactive intestinal polypeptide (VIP) potentiates the behavioral effect of substance… [PMID: 1723799]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) potentiates the behavioral effect of substance P intrathecal administration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Onoue S et al. (2004). Structure-activity relationship of synthetic truncated analogues of vasoactive… [PMID: 14729396]
Laboratory literature summary: Structure-activity relationship of synthetic truncated analogues of vasoactive intestinal peptide (VIP): an enhancement in the activity…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mack D et al. (1997). Vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) in prostate… [PMID: 9135509]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) in prostate carcinoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1978). Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma [PMID: 717170]
Laboratory literature summary: Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hajós F et al. (1990). Vasoactive intestinal polypeptide (VIP) containing cells in the developing rat… [PMID: 2240594]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) containing cells in the developing rat occipital hemisphere. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1977). Vasoactive intestinal polypeptide (VIP) in research subjects cerebrospinal fluid [PMID: 851866]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) in research subjects cerebrospinal fluid. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sagar SM (1987). Vasoactive intestinal polypeptide (VIP) immunohistochemistry in the rabbit retina [PMID: 3319043]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) immunohistochemistry in the rabbit retina. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Morris JL et al. (1989). Analogues of vasoactive intestinal peptide (VIP) contract the guinea-pig uterine… [PMID: 2542061]
Laboratory literature summary: Analogues of vasoactive intestinal peptide (VIP) contract the guinea-pig uterine artery but do not antagonize VIP-induced relaxations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lundberg JM et al. (1979). Peptides in the cat carotid body (glomus caroticum): VIP-, enkephalin-, and substance… [PMID: 94238]
Laboratory literature summary: Peptides in the cat carotid body (glomus caroticum): VIP-, enkephalin-, and substance P-like immunoreactivity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
el Battari A et al. (1985). Modification of HT 29 cell response to the vasoactive intestinal peptide (VIP) by… [PMID: 3006797]
Laboratory literature summary: Modification of HT 29 cell response to the vasoactive intestinal peptide (VIP) by membrane fluidization. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hill JM et al. (1994). Blockade of VIP during neonatal development induces neuronal damage and increases VIP… [PMID: 7832475]
Laboratory literature summary: Blockade of VIP during neonatal development induces neuronal damage and increases VIP and VIP receptors in brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kawatani M et al. (1985). Selective facilitatory effect of vasoactive intestinal polypeptide (VIP) on muscarinic… [PMID: 3891019]
Laboratory literature summary: Selective facilitatory effect of vasoactive intestinal polypeptide (VIP) on muscarinic firing in vesical ganglia of the cat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1979). Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP) [PMID: 225790]
Laboratory literature summary: Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1983). Multiplicity of receptors for vasoactive intestinal polypeptide (VIP): differential… [PMID: 6312430]
Laboratory literature summary: Multiplicity of receptors for vasoactive intestinal polypeptide (VIP): differential effects of apamin on binding in brain, uterus and liver. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
King SC et al. (1989). Autoradiographic localization of binding sites for galanin and VIP in small intestine [PMID: 2474152]
Laboratory literature summary: Autoradiographic localization of binding sites for galanin and VIP in small intestine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hossdorf T et al. (1982). Radioimmunoassay for vasoactive intestinal polypeptide (VIP) in plasma before and… [PMID: 7129338]
Laboratory literature summary: Radioimmunoassay for vasoactive intestinal polypeptide (VIP) in plasma before and during endoscopic examinations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pincus DW et al. (1994). Trophic mechanisms regulate mitotic neuronal precursors: role of vasoactive intestinal… [PMID: 7850470]
Laboratory literature summary: Trophic mechanisms regulate mitotic neuronal precursors: role of vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yamaguchi Y et al. (1994). Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat [PMID: 8208360]
Laboratory literature summary: Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ngezahayo A et al. (1994). Regulation of gap junctional coupling in isolated pancreatic acinar cell pairs by… [PMID: 7520502]
Laboratory literature summary: Regulation of gap junctional coupling in isolated pancreatic acinar cell pairs by cholecystokinin-octapeptide, vasoactive intestinal…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Carlquist M et al. (1979). Isolation and characterization of bovine vasoactive intestinal peptide (VIP) [PMID: 520589]
Laboratory literature summary: Isolation and characterization of bovine vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Makhlouf GM et al. (1978). Effects of synthetic vasoactive intestinal peptide (VIP), secretin and their partial… [PMID: 349569]
Laboratory literature summary: Effects of synthetic vasoactive intestinal peptide (VIP), secretin and their partial sequences on gastric secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Helm G et al. (1985). Changes in oviductal VIP content induced by sex steroids and inhibitory effect of VIP… [PMID: 4072707]
Laboratory literature summary: Changes in oviductal VIP content induced by sex steroids and inhibitory effect of VIP on spontaneous oviductal contractility. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Paul S et al. (1986). Solubilization of active receptors for VIP from guinea pig lung [PMID: 3018692]
Laboratory literature summary: Solubilization of active receptors for VIP from guinea pig lung. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Katayama T (1989). [The effect of vasoactive intestinal polypeptide (VIP) on ocular inflammation in… [PMID: 2546409]
Laboratory literature summary: [The effect of vasoactive intestinal polypeptide (VIP) on ocular inflammation in rabbit ocular tissue]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kato Y et al. (1984). Role of vasoactive intestinal polypeptide (VIP) in regulating the pituitary function… [PMID: 6089138]
Laboratory literature summary: Role of vasoactive intestinal polypeptide (VIP) in regulating the pituitary function in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sundler F et al. (1977). Neuronal localization of pancreatic polypeptide (PP) and vasoactive intestinal peptide… [PMID: 861774]
Laboratory literature summary: Neuronal localization of pancreatic polypeptide (PP) and vasoactive intestinal peptide (VIP) immunoreactivity in the earthworm…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Eiden LE et al. (1983). Primary cultures of bovine chromaffin cells synthesize and secrete vasoactive… [PMID: 6888186]
Laboratory literature summary: Primary cultures of bovine chromaffin cells synthesize and secrete vasoactive intestinal polypeptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schaffalitzky de Muckadell OB et al. (1977). Release of vasoactive intestinal polypeptide (VIP) by electric stimulation of the… [PMID: 830595]
Laboratory literature summary: Release of vasoactive intestinal polypeptide (VIP) by electric stimulation of the vagal nerves. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schmidt P et al. (1993). Release of immunoreactive somatostatin, vasoactive intestinal polypeptide (VIP), and… [PMID: 7683399]
Laboratory literature summary: Release of immunoreactive somatostatin, vasoactive intestinal polypeptide (VIP), and galanin during propulsive complexes in isolated pig…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fedele D et al. (1988). Laboratory research record on VIP (Vasoactive Intestinal ) [PMID: 3063932]
PubMed laboratory record discussing VIP (Vasoactive Intestinal ) in a research context. Review the full methods and limitations on PubMed; research use only.
Fabre C et al. (1993). Glycosylation of VIP receptors: a molecular basis for receptor heterogeneity [PMID: 8392717]
Laboratory literature summary: Glycosylation of VIP receptors: a molecular basis for receptor heterogeneity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pawelzik H et al. (1992). Actions of vasoactive intestinal polypeptide (VIP) on neocortical neurons of the rat… [PMID: 1491801]
Laboratory literature summary: Actions of vasoactive intestinal polypeptide (VIP) on neocortical neurons of the rat in vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Takeyama M et al. (1989). Immuno-affinity purification of specific antibodies against vasoactive intestinal… [PMID: 2752498]
Laboratory literature summary: Immuno-affinity purification of specific antibodies against vasoactive intestinal polypeptide (VIP) on VIP (1-10)-linked…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Charpentier G et al. (1982). VIP test in prolactinomas and in normal subjects [PMID: 7126775]
Laboratory literature summary: VIP test in prolactinomas and in normal subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Markos F et al. (2006). Vagal postganglionic origin of vasoactive intestinal polypeptide (VIP) mediating the… [PMID: 16896725]
Laboratory literature summary: Vagal postganglionic origin of vasoactive intestinal polypeptide (VIP) mediating the vagal tachycardia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Krowicki Z et al. (1983). [Cholecystokinin and vasoactive intestinal polypeptide (VIP) in the central nervous… [PMID: 6138762]
Laboratory literature summary: [Cholecystokinin and vasoactive intestinal polypeptide (VIP) in the central nervous system]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bornstein SR et al. (1996). Cellular communication in the neuro-adrenocortical axis: role of vasoactive intestinal… [PMID: 8969945]
Laboratory literature summary: Cellular communication in the neuro-adrenocortical axis: role of vasoactive intestinal polypeptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Thulin L et al. (1984). Circulatory effects of VIP in anesthetized man [PMID: 6473160]
Laboratory literature summary: Circulatory effects of VIP in anesthetized man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Naruse S et al. (1992). Vasodilator action of guinea pig vasoactive intestinal polypeptide (VIP): comparison… [PMID: 1289976]
Laboratory literature summary: Vasodilator action of guinea pig vasoactive intestinal polypeptide (VIP): comparison with common mammalian VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Prost A et al. (1984). Activation of the cAMP-generating system by vasoactive intestinal polypeptide (VIP) in… [PMID: 6085015]
Laboratory literature summary: Activation of the cAMP-generating system by vasoactive intestinal polypeptide (VIP) in the research subjects laryngeal malignant cell…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vandermeers A et al. (1984). Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with… [PMID: 6692928]
Laboratory literature summary: Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP- and secretin-like properties (helodermin) from…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Scheibel E et al. (1982). Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours [PMID: 6295059]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hirata Y et al. (1982). [Vasoactive intestinal peptide (VIP) and epidermal growth factor (EGF)] [PMID: 6981718]
Laboratory literature summary: [Vasoactive intestinal peptide (VIP) and epidermal growth factor (EGF)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nicosia S et al. (1983). The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone [PMID: 6311891]
Laboratory literature summary: The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Eiden LE et al. (1982). Distribution of vasoactive intestinal polypeptide (VIP) in the rat brain stem nuclei [PMID: 7055688]
Laboratory literature summary: Distribution of vasoactive intestinal polypeptide (VIP) in the rat brain stem nuclei. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Maletti M et al. (1980). Ontogeny and immunoreactive forms of vasoactive intestinal peptide (VIP) in rat brain [PMID: 7386117]
Laboratory literature summary: Ontogeny and immunoreactive forms of vasoactive intestinal peptide (VIP) in rat brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shirahase H et al. (1994). Structure-activity relationships for relaxation of smooth muscle by VIP [PMID: 8008642]
Laboratory literature summary: Structure-activity relationships for relaxation of smooth muscle by VIP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Altiere RJ et al. (1984). VIP as a bronchodilator [PMID: 6140466]
Laboratory literature summary: VIP as a bronchodilator. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Uddman R et al. (1980). Vasoactive intestinal peptide (VIP) occurs in nerves of the pineal gland [PMID: 6998720]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) occurs in nerves of the pineal gland. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Goadsby PJ et al. (1985). Extracranial vasodilation mediated by vasoactive intestinal polypeptide (VIP) [PMID: 2983841]
Laboratory literature summary: Extracranial vasodilation mediated by vasoactive intestinal polypeptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bloom S et al. (1978). Effect of vasoactive intestinal peptide (VIP) and other neuropeptides on cAMP… [PMID: 205298]
Laboratory literature summary: Effect of vasoactive intestinal peptide (VIP) and other neuropeptides on cAMP accumulation in brain slices [proceedings]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Poulin P et al. (1986). Autoradiographic localization of binding sites for vasoactive intestinal peptide (VIP)… [PMID: 3756513]
Laboratory literature summary: Autoradiographic localization of binding sites for vasoactive intestinal peptide (VIP) in bovine cerebral arteries. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bodanszky M et al. (1974). Synthesis of the vasoactive intestinal peptide (VIP) [PMID: 4854585]
Laboratory literature summary: Synthesis of the vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ottesen B et al. (1985). Vasoactive intestinal polypeptide (VIP) and peripheral vasodilation [PMID: 3993388]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) and peripheral vasodilation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Juarranz MG et al. (1992). Somatostatin inhibits VIP- and forskolin-stimulated cyclic AMP accumulation in… [PMID: 1364040]
Laboratory literature summary: Somatostatin inhibits VIP- and forskolin-stimulated cyclic AMP accumulation in enterocytes from rat jejunum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tumilasci OR et al. (1986). Thyroid hormone modulation of VIP's induced salivary secretion in the submaxillary… [PMID: 3700977]
Laboratory literature summary: Thyroid hormone modulation of VIP's induced salivary secretion in the submaxillary glands of rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rossiter A et al. (1994). Is VIP a key neuropeptide in achalasia? [PMID: 8174904]
Laboratory literature summary: Is VIP a key neuropeptide in achalasia?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fischer J et al. (1989). [The significance of vasoactive intestinal polypeptide (VIP) in analytical assessment… [PMID: 2608648]
Laboratory literature summary: [The significance of vasoactive intestinal polypeptide (VIP) in analytical assessment of sleep apnea syndrome]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hagiwara M et al. (1990). Vasoactive intestinal polypeptide (VIP) stimulates fibrinolytic system in the rat [PMID: 2273652]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) stimulates fibrinolytic system in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gu J et al. (1984). Decrease of vasoactive intestinal polypeptide (VIP) in the penises from impotent… [PMID: 6146864]
Laboratory literature summary: Decrease of vasoactive intestinal polypeptide (VIP) in the penises from impotent research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yoshihara S et al. (1989). [Using specific radioimmunoassay for guinea pig VIP (GP VIP), immunoreactive GP VIP… [PMID: 2818211]
Laboratory literature summary: [Using specific radioimmunoassay for guinea pig VIP (GP VIP), immunoreactive GP VIP levels in respiratory tract tissue of normal and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Uddman R et al. (1980). The origin of vasoactive intestinal polypeptide (VIP) nerves in the feline nasal mucosa [PMID: 7405573]
Laboratory literature summary: The origin of vasoactive intestinal polypeptide (VIP) nerves in the feline nasal mucosa. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Krowicki Z et al. (1983). [Gastrointestinal hormones and related neuropeptides. III. The secretin group:… [PMID: 6387678]
Laboratory literature summary: [Gastrointestinal hormones and related neuropeptides. III. The secretin group: vasoactive intestinal polypeptide (VIP)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fernández-Moreno MD et al. (1989). Effect of intestinal ischaemia on intestinal VIP levels and VIP interaction with… [PMID: 2573460]
Laboratory literature summary: Effect of intestinal ischaemia on intestinal VIP levels and VIP interaction with intestinal epithelial cells from rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Makhlouf GM (1977). Distinct mechanisms for stimulation of intestinal secretion by vasoactive intestinal… [PMID: 830592]
Laboratory literature summary: Distinct mechanisms for stimulation of intestinal secretion by vasoactive intestinal peptide (VIP) and glucagon. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gianotti A et al. (1987). [Changes induced by vasointestinal peptide (VIP) and diltiazem on bronchoreactivity… [PMID: 3508572]
Laboratory literature summary: [Changes induced by vasointestinal peptide (VIP) and diltiazem on bronchoreactivity specific and aspecific aspects]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kachelhoffer J et al. (1979). [Vasoactive intestinal polypeptide (VIP) (author's transl)] [PMID: 499699]
Laboratory literature summary: [Vasoactive intestinal polypeptide (VIP) (author's transl)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Larsson LI (1977). Ultrastructural localization of a new neuronal peptide (VIP) [PMID: 336585]
Laboratory literature summary: Ultrastructural localization of a new neuronal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mitchell SJ et al. (1982). The pharmacokinetics of VIP in dog and pig [PMID: 7128757]
Laboratory literature summary: The pharmacokinetics of VIP in dog and pig. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wiik P et al. (1985). Binding of vasoactive intestinal polypeptide (VIP) by research subjects blood… [PMID: 2999883]
Laboratory literature summary: Binding of vasoactive intestinal polypeptide (VIP) by research subjects blood monocytes: demonstration of specific binding sites. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Beyerman HC et al. (1981). Synthesis, biological and immunochemical properties of analogues of secretin and… [PMID: 7300581]
Laboratory literature summary: Synthesis, biological and immunochemical properties of analogues of secretin and vasoactive intestinal peptide (VIP): the vasectrins. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Miller RJ (1980). Vasoactive intestinal polypeptide (VIP) [PMID: 7266081]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Robberecht P (1978). [Membrane receptors of vasoactive intestinal peptide (VIP): hormone and… [PMID: 84566]
Laboratory literature summary: [Membrane receptors of vasoactive intestinal peptide (VIP): hormone and neurotransmitter (proceedings)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Riederer A et al. (1995). [Current immunohistochemical results of localization of vasoactive intestinal… [PMID: 8672200]
Laboratory literature summary: [Current immunohistochemical results of localization of vasoactive intestinal polypeptide (VIP) in nasal mucosa of the research subjects]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Marongiu L et al. (1993). Peptidergic (VIP) nerves in normal research subjects pancreas and in pancreatitis: an… [PMID: 8443423]
Laboratory literature summary: Peptidergic (VIP) nerves in normal research subjects pancreas and in pancreatitis: an immunohistochemical study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Laburthe M (1985). [Vasoactive intestinal peptide (VIP): a ubiquitous neuropeptide member of structural… [PMID: 3006796]
Laboratory literature summary: [Vasoactive intestinal peptide (VIP): a ubiquitous neuropeptide member of structural family of regulatory peptides]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Watanabe S (2010). [Vasoactive intestinal polypeptide (VIP)] [PMID: 20963892]
Laboratory literature summary: [Vasoactive intestinal polypeptide (VIP)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yamaguchi K et al. (1980). The pressence of macromolecular vasoactive intestinal polypeptide (VIP) in… [PMID: 7409387]
Laboratory literature summary: The pressence of macromolecular vasoactive intestinal polypeptide (VIP) in VIP-producing tumors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Maggi CA et al. (1989). Release of VIP- but not CGRP-like immunoreactivity by capsaicin from the research… [PMID: 2786168]
Laboratory literature summary: Release of VIP- but not CGRP-like immunoreactivity by capsaicin from the research subjects isolated small intestine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (1982). VIP as biochemical marker for PMNs [PMID: 7061922]
Laboratory literature summary: VIP as biochemical marker for PMNs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vagne M et al. (1976). Effect of secretin, glucagon and VIP on gallbladder contraction [PMID: 955325]
Laboratory literature summary: Effect of secretin, glucagon and VIP on gallbladder contraction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brayden JE et al. (1986). Evidence that vasoactive intestinal polypeptide (VIP) mediates neurogenic vasodilation… [PMID: 3810719]
Laboratory literature summary: Evidence that vasoactive intestinal polypeptide (VIP) mediates neurogenic vasodilation of feline cerebral arteries. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kashimoto K et al. (1996). Structure-activity relationship studies of PACAP-27 and VIP analogues [PMID: 8993431]
Laboratory literature summary: Structure-activity relationship studies of PACAP-27 and VIP analogues. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sandström R et al. (1981). Vasoactive intestinal peptide (VIP) secreting oncology research models of the pancreas [PMID: 6275768]
Laboratory literature summary: Vasoactive intestinal peptide (VIP) secreting oncology research models of the pancreas. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
McFarlin DR et al. (1995). Sequence of a cDNA encoding chicken vasoactive intestinal peptide (VIP) [PMID: 7890166]
Laboratory literature summary: Sequence of a cDNA encoding chicken vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Emson PC et al. (1978). Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked… [PMID: 630399]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked release from rat hypothalamus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Emson PC et al. (1979). Development of vasoactive intestinal polypeptide (VIP) containing neurones in the rat… [PMID: 387178]
Laboratory literature summary: Development of vasoactive intestinal polypeptide (VIP) containing neurones in the rat brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zeytin FN et al. (1985). Rat hypothalamic GRF elicits its biologic action in GH3 cells by interaction with VIP-… [PMID: 2985067]
Laboratory literature summary: Rat hypothalamic GRF elicits its biologic action in GH3 cells by interaction with VIP- preferring receptor site(s). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2006). VIP, PACAP, and related peptides: from gene to research protocol. Proceedings of the… [PMID: 16991209]
Laboratory literature summary: VIP, PACAP, and related peptides: from gene to research protocol. Proceedings of the 7th International Symposium on VIP, PACAP, and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Borghi C et al. (1979). Vasoactive intestinal polypeptide (VIP) stimulates adenylate cyclase in selected areas… [PMID: 763070]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) stimulates adenylate cyclase in selected areas of rat brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
McGregor GP et al. (1984). Comparative distribution of vasoactive intestinal polypeptide (VIP), substance P and… [PMID: 6202546]
Laboratory literature summary: Comparative distribution of vasoactive intestinal polypeptide (VIP), substance P and PHI in the enteric sphincters of the cat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (1983). Abstracts of the First International Symposium on Vasoactive Intestinal Peptide (VIP)… [PMID: 6688676]
Laboratory literature summary: Abstracts of the First International Symposium on Vasoactive Intestinal Peptide (VIP) and Related Peptides. Brussels, Belgium, September…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kalfin R et al. (1991). The effect of vasoactive intestinal polypeptide (VIP) on the canine gallbladder motility [PMID: 1687549]
Laboratory literature summary: The effect of vasoactive intestinal polypeptide (VIP) on the canine gallbladder motility. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bloom SR et al. (1973). Proceedings: The distribution of vasoactive intestinal peptide (VIP) in the primate… [PMID: 4202273]
Laboratory literature summary: Proceedings: The distribution of vasoactive intestinal peptide (VIP) in the primate gastrointestinal tract and characterization of VIP…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kuroshima A et al. (1986). Absence of vasoactive intestinal peptide (VIP) innervation of adipose tissues [PMID: 3527922]
Laboratory literature summary: Absence of vasoactive intestinal peptide (VIP) innervation of adipose tissues. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Modlin IM et al. (1978). Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemia [PMID: 639959]
Laboratory literature summary: Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Messell T et al. (1991). Neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP), but not galanin, are… [PMID: 1721082]
Laboratory literature summary: Neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP), but not galanin, are autonomic cotransmitters in the porcine pancreas. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1991). Vasoactive intestinal polypeptide (VIP) in lung function and disease [PMID: 1687288]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) in lung function and disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bottino G et al. (1990). [Variations of vasoactive intestinal peptide (VIP) concentration in the lung of… [PMID: 2080314]
Laboratory literature summary: [Variations of vasoactive intestinal peptide (VIP) concentration in the lung of asthmatic research subjects]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Emson PC et al. (1979). Vasoactive intestinal polypeptide (VIP): distribution in normal research subjects… [PMID: 158404]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP): distribution in normal research subjects brain and in Huntington's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lundberg JM et al. (1984). Neuropeptides with vascular activity: VIP, PHI, NPY and substance P [PMID: 6085266]
Laboratory literature summary: Neuropeptides with vascular activity: VIP, PHI, NPY and substance P. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sjöqvist A et al. (1983). Effect of apamin on release of vasoactive intestinal polypeptide (VIP) from the cat… [PMID: 6139935]
Laboratory literature summary: Effect of apamin on release of vasoactive intestinal polypeptide (VIP) from the cat intestines. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ebeid AM et al. (1977). Release of vasoactive intestinal peptide (VIP) by intraluminal osmotic stimuli [PMID: 875384]
Laboratory literature summary: Release of vasoactive intestinal peptide (VIP) by intraluminal osmotic stimuli. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bataille D et al. (1981). [Effect of vasoactive intestinal peptide (VIP) on prolactin secretion in man] [PMID: 6786785]
Laboratory literature summary: [Effect of vasoactive intestinal peptide (VIP) on prolactin secretion in man]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Larsson LI et al. (1976). Immunohistochemical localization of a vasodilatory polypeptide (VIP) in… [PMID: 953744]
Laboratory literature summary: Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Triepel J (1982). Vasoactive intestinal polypeptide (VIP) in the medulla oblongata of the guinea pig [PMID: 7041012]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) in the medulla oblongata of the guinea pig. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1976). Letter: Cautious interpretation of plasma vip levels [PMID: 1250287]
Laboratory literature summary: Letter: Cautious interpretation of plasma vip levels. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dupont C et al. (1978). [Receptors for vasoactic intestinal peptide (VIP) in research subjects colonic… [PMID: 206381]
Laboratory literature summary: [Receptors for vasoactic intestinal peptide (VIP) in research subjects colonic adenocarcinoma membranes: specific binding and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ohta H et al. (1985). Inhibition by antiserum to vasoactive intestinal polypeptide (VIP) of prolactin… [PMID: 3872804]
Laboratory literature summary: Inhibition by antiserum to vasoactive intestinal polypeptide (VIP) of prolactin secretion induced by serotonin in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhang RX (1993). [Study on plasma levels of vasoactive intestinal peptide (VIP) in research subjects… [PMID: 8217299]
Laboratory literature summary: [Study on plasma levels of vasoactive intestinal peptide (VIP) in research subjects with allergic rhinitis]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Davison JS et al. (1991). Evidence that vasoactive intestinal peptide (VIP) is an inhibitory transmitter in the… [PMID: 1686329]
Laboratory literature summary: Evidence that vasoactive intestinal peptide (VIP) is an inhibitory transmitter in the ferret gastric corpus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ruberg M et al. (1978). Stimulation of prolactin release by vasoactive intestinal peptide (VIP) [PMID: 710507]
Laboratory literature summary: Stimulation of prolactin release by vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fontaine JL et al. (1977). [Sympathoma and diarrhea caused by hypersecretion of vasoactive intestinal peptide… [PMID: 907439]
Laboratory literature summary: [Sympathoma and diarrhea caused by hypersecretion of vasoactive intestinal peptide (VIP). Apropos of a further case]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Devine BL et al. (1978). Cyclical release of vasoactive intestinal polypeptide (VIP) from a pancreatic islet… [PMID: 215990]
Laboratory literature summary: Cyclical release of vasoactive intestinal polypeptide (VIP) from a pancreatic islet cell apudoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ottaway CA (1995). Interaction of a sulfhydryl analogue of vasoactive intestinal peptide (VIP) with… [PMID: 8525988]
Laboratory literature summary: Interaction of a sulfhydryl analogue of vasoactive intestinal peptide (VIP) with murine lymphocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ottesen B et al. (1984). Increased endometrial clearance of 85krypton evoked by VIP in rabbits [PMID: 6147955]
Laboratory literature summary: Increased endometrial clearance of 85krypton evoked by VIP in rabbits. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Leupold D et al. (1977). [Chronic diarrhea, ganglioneuroma and vasoactive intestinal polypeptide (VIP)] [PMID: 876203]
Laboratory literature summary: [Chronic diarrhea, ganglioneuroma and vasoactive intestinal polypeptide (VIP)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bundgaard A et al. (1983). Pretreatment of exercise-induced asthma with inhaled vasoactive intestinal peptide (VIP) [PMID: 6578098]
Laboratory literature summary: Pretreatment of exercise-induced asthma with inhaled vasoactive intestinal peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Willis E et al. (1981). Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in… [PMID: 7348038]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in penile erection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vertongen P et al. (1998). Autoradiographic visualization of the receptor subclasses for vasoactive intestinal… [PMID: 9928040]
Laboratory literature summary: Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Suzuki Y et al. (1983). Vasodilatory effects of vasoactive intestinal polypeptide (VIP) on isolated rat arteries [PMID: 6889362]
Laboratory literature summary: Vasodilatory effects of vasoactive intestinal polypeptide (VIP) on isolated rat arteries. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Burhol PG et al. (1985). Diurnal profiles of plasma cholecystokinin (CCK) and vasoactive intestinal polypeptide… [PMID: 4040993]
Laboratory literature summary: Diurnal profiles of plasma cholecystokinin (CCK) and vasoactive intestinal polypeptide (VIP) in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Prieto JC et al. (1980). No effect of starvation on vasoactive intestinal peptide (VIP) receptors in intestinal… [PMID: 6248446]
Laboratory literature summary: No effect of starvation on vasoactive intestinal peptide (VIP) receptors in intestinal epithelial cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Raiteri M et al. (1987). Vasoactive intestinal polypeptide (VIP) potentiates the muscarinic stimulation of… [PMID: 3030770]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) potentiates the muscarinic stimulation of phosphoinositide turnover in rat cerebral cortex. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sundler F et al. (1979). Cellular localization and ontogeny of immunoreactive vasoactive intestinal polypeptide… [PMID: 421252]
Laboratory literature summary: Cellular localization and ontogeny of immunoreactive vasoactive intestinal polypeptide (VIP) in the chicken gut. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Christophe J et al. (1984). [Is vasoactive intestinal peptide (VIP) an essential neuropeptide for the heart?] [PMID: 6100236]
Laboratory literature summary: [Is vasoactive intestinal peptide (VIP) an essential neuropeptide for the heart?]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Borghi C et al. (1979). Adenylate cyclase of rat pituitary gland: stimulation by vasoactive intestinal… [PMID: 520579]
Laboratory literature summary: Adenylate cyclase of rat pituitary gland: stimulation by vasoactive intestinal polypeptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lezoche E (1978). Vasoactive intestinal polypeptide (VIP) concentration after small bowel resection [PMID: 640355]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) concentration after small bowel resection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Piga M et al. (1984). Vasoactive intestinal polypeptide (VIP) plasma levels in chronic renal failure [PMID: 6512602]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) plasma levels in chronic renal failure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Leonardi R et al. (1981). [The vasoactive intestinal polypeptide (VIP). Its role in the physiology of the… [PMID: 6111769]
Laboratory literature summary: [The vasoactive intestinal polypeptide (VIP). Its role in the physiology of the digestive system]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Warnick JE et al. (1986). Resistance of afterhyperpolarizations in hippocampal pyramidal cells to prostaglandins… [PMID: 3022195]
Laboratory literature summary: Resistance of afterhyperpolarizations in hippocampal pyramidal cells to prostaglandins and vasoactive intestinal polypeptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1978). Distribution of vasoactive intestinal polypeptide (VIP) in the porcine central nervous… [PMID: 551125]
Laboratory literature summary: Distribution of vasoactive intestinal polypeptide (VIP) in the porcine central nervous system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ottesen B et al. (1979). Vasoactive intestinal polypeptide (VIP) inhibits oxytocin induced activity of the… [PMID: 539459]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP) inhibits oxytocin induced activity of the rabbit myometrium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fujikado T et al. (1987). [Influence of vasoactive intestinal polypeptide (VIP) upon the chick ERG during… [PMID: 3448912]
Laboratory literature summary: [Influence of vasoactive intestinal polypeptide (VIP) upon the chick ERG during development]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Denac M et al. (1987). Relaxation of ruminal smooth muscle by vasoactive intestinal polypeptide (VIP) [PMID: 3113113]
Laboratory literature summary: Relaxation of ruminal smooth muscle by vasoactive intestinal polypeptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Larsson LI et al. (1978). Innervation of the pancreas by vasoactive intestinal polypeptide (VIP) immunoreactive… [PMID: 642723]
Laboratory literature summary: Innervation of the pancreas by vasoactive intestinal polypeptide (VIP) immunoreactive nerves. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rotsztejn W et al. (1980). [Dexamethasone regulation of the prolactin release induced by vasoactive intestinal… [PMID: 6769606]
Laboratory literature summary: [Dexamethasone regulation of the prolactin release induced by vasoactive intestinal peptide (VIP)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kato Y (1989). [Regulation of pituitary prolactin secretion by vasoactive intestinal polypeptide… [PMID: 2483167]
Laboratory literature summary: [Regulation of pituitary prolactin secretion by vasoactive intestinal polypeptide (VIP) and galanin]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jaeger E et al. (1996). Structure-activity studies on VIP: IV. The synthetic agonist… [PMID: 8993430]
Laboratory literature summary: Structure-activity studies on VIP: IV. The synthetic agonist helodermin-fragment-(1-28)-amide is a potent VIP-agonist with prolonged…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dodd J et al. (1979). Excitation of CA1 neurones of the rat hippocampus by the octacosapeptide, vasoactive… [PMID: 454920]
Laboratory literature summary: Excitation of CA1 neurones of the rat hippocampus by the octacosapeptide, vasoactive intestinal polypeptide (VIP) [proceedings]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Feingold KR et al. (2000). Vasoactive Intestinal Peptide-Secreting oncology research models (VIPoma) [PMID: 25905195]
Laboratory literature summary: Vasoactive Intestinal Peptide-Secreting oncology research models (VIPoma). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1986). Vasoactive intestinal peptide [PMID: 2872248]
Laboratory literature summary: Vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Una Cidon E (2022). Vasoactive intestinal peptide secreting oncology research models: An overview [PMID: 35582098]
Laboratory literature summary: Vasoactive intestinal peptide secreting oncology research models: An overview. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Siddappa PK et al. (2019). Vasoactive Intestinal Peptide-Secreting Tumors: A Review [PMID: 31609932]
Laboratory literature summary: Vasoactive Intestinal Peptide-Secreting Tumors: A Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Henning RJ et al. (2001). Vasoactive intestinal peptide: cardiovascular effects [PMID: 11121793]
Laboratory literature summary: Vasoactive intestinal peptide: cardiovascular effects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gonzales J et al. (2024). The Microbiota Conducts the Vasoactive Intestinal Polypeptide Orchestra in the Small… [PMID: 38109941]
Laboratory literature summary: The Microbiota Conducts the Vasoactive Intestinal Polypeptide Orchestra in the Small Intestine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Thomas J et al. (2024). Vasoactive Intestinal Polypeptide Secreting MS Neuroblastoma [PMID: 39691933]
Laboratory literature summary: Vasoactive Intestinal Polypeptide Secreting MS Neuroblastoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1989). Vasoactive intestinal polypeptide and asthma [PMID: 2710206]
Laboratory literature summary: Vasoactive intestinal polypeptide and asthma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhong HL et al. (2023). The role of vasoactive intestinal peptide in pulmonary diseases [PMID: 37742737]
Laboratory literature summary: The role of vasoactive intestinal peptide in pulmonary diseases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J (1980). Vasoactive intestinal polypeptide [PMID: 6107190]
Laboratory literature summary: Vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jiang W et al. (2016). Role of vasoactive intestinal peptide in osteoarthritis [PMID: 27553659]
Laboratory literature summary: Role of vasoactive intestinal peptide in osteoarthritis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sethi V et al. (2005). Liposomal vasoactive intestinal peptide [PMID: 15721392]
Laboratory literature summary: Liposomal vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Forssmann WG et al. (1988). Vasoactive intestinal peptide in the heart [PMID: 3291696]
Laboratory literature summary: Vasoactive intestinal peptide in the heart. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Goff KM et al. (2021). A Role for Vasoactive Intestinal Peptide Interneurons in Neurodevelopmental Disorders [PMID: 33794534]
Laboratory literature summary: A Role for Vasoactive Intestinal Peptide Interneurons in Neurodevelopmental Disorders. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
He Y et al. (2022). Vasoactive intestinal peptide: a potential target for antiviral research protocol [PMID: 35770640]
Laboratory literature summary: Vasoactive intestinal peptide: a potential target for antiviral research protocol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1982). Vasoactive intestinal polypeptide: functional aspects [PMID: 6129023]
Laboratory literature summary: Vasoactive intestinal polypeptide: functional aspects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Asano S et al. (2022). Vasoactive intestinal peptide-VIPR2 signaling regulates oncology research models cell… [PMID: 36237322]
Laboratory literature summary: Vasoactive intestinal peptide-VIPR2 signaling regulates oncology research models cell migration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhang R et al. (2018). Immunomodulatory vasoactive intestinal peptide amphiphile micelles [PMID: 29896593]
Laboratory literature summary: Immunomodulatory vasoactive intestinal peptide amphiphile micelles. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schwerdtfeger LA et al. (2020). Vasoactive intestinal peptide regulates ileal goblet cell production in mice [PMID: 32026594]
Laboratory literature summary: Vasoactive intestinal peptide regulates ileal goblet cell production in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Groneberg DA et al. (2001). Vasoactive intestinal polypeptide as mediator of asthma [PMID: 11603952]
Laboratory literature summary: Vasoactive intestinal polypeptide as mediator of asthma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Satitpitakul V et al. (2018). Vasoactive Intestinal Peptide Promotes Corneal Allograft Survival [PMID: 30097165]
Laboratory literature summary: Vasoactive Intestinal Peptide Promotes Corneal Allograft Survival. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cakmak AI et al. (2017). Vasoactive intestinal peptide, a promising agent for myopia? [PMID: 28251078]
Laboratory literature summary: Vasoactive intestinal peptide, a promising agent for myopia?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shi L et al. (2021). Laboratory research record on VIP (Vasoactive Intestinal ) [PMID: 33999216]
PubMed laboratory record discussing VIP (Vasoactive Intestinal ) in a research context. Review the full methods and limitations on PubMed; research use only.
Deng G et al. (2017). The effects of vasoactive intestinal peptide in neurodegenerative disorders [PMID: 27786097]
Laboratory literature summary: The effects of vasoactive intestinal peptide in neurodegenerative disorders. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Porter JP et al. (1988). Vasoactive intestinal peptide and renin secretion [PMID: 3291698]
Laboratory literature summary: Vasoactive intestinal peptide and renin secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1988). Vasoactive intestinal peptide in the lung [PMID: 2898912]
Laboratory literature summary: Vasoactive intestinal peptide in the lung. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hill JM (2007). Vasoactive intestinal peptide in neurodevelopmental disorders: investigational potential [PMID: 17430171]
Laboratory literature summary: Vasoactive intestinal peptide in neurodevelopmental disorders: investigational potential. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wenger GD et al. (1990). Vasoactive intestinal peptide. Messenger in a neuroimmune axis [PMID: 2165755]
Laboratory literature summary: Vasoactive intestinal peptide. Messenger in a neuroimmune axis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Delgado M et al. (2013). Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions [PMID: 22139413]
Laboratory literature summary: Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vosko AM et al. (2007). Vasoactive intestinal peptide and the mammalian circadian system [PMID: 17572414]
Laboratory literature summary: Vasoactive intestinal peptide and the mammalian circadian system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Muñoz-Flores C et al. (2023). Immunomodulatory role of vasoactive intestinal peptide and ghrelin in Oncorhynchus mykiss [PMID: 38149209]
Laboratory literature summary: Immunomodulatory role of vasoactive intestinal peptide and ghrelin in Oncorhynchus mykiss. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Benarroch EE (1980). [VIP: not only a vasoactive intestinal polypeptide] [PMID: 22167708]
Laboratory literature summary: [VIP: not only a vasoactive intestinal polypeptide]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J (1979). Vasoactive intestinal polypeptide: measurement, distribution and putative… [PMID: 39014]
Laboratory literature summary: Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hermel M et al. (2021). Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis [PMID: 33889374]
Laboratory literature summary: Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li M et al. (2024). Heparin Oligosaccharides as Vasoactive Intestinal Peptide Inhibitors via their Binding… [PMID: 38284716]
Laboratory literature summary: Heparin Oligosaccharides as Vasoactive Intestinal Peptide Inhibitors via their Binding Process Characterization. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dinsmore WW et al. (2008). Laboratory research record on VIP (Vasoactive Intestinal ) [PMID: 18485029]
PubMed laboratory record discussing VIP (Vasoactive Intestinal ) in a research context. Review the full methods and limitations on PubMed; research use only.
Leceta J et al. (2007). Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation [PMID: 18073504]
Laboratory literature summary: Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Carrión M et al. (2020). Vasoactive intestinal peptide axis is dysfunctional in research subjects with Graves'… [PMID: 32747757]
Laboratory literature summary: Vasoactive intestinal peptide axis is dysfunctional in research subjects with Graves' disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Surrenti C et al. (1993). Colonic vasoactive intestinal polypeptide in ulcerative colitis [PMID: 8298608]
Laboratory literature summary: Colonic vasoactive intestinal polypeptide in ulcerative colitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Prysor-Jones RA et al. (1988). Vasoactive intestinal peptide and anterior pituitary function [PMID: 3076850]
Laboratory literature summary: Vasoactive intestinal peptide and anterior pituitary function. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Delgado M et al. (2004). The significance of vasoactive intestinal peptide in immunomodulation [PMID: 15169929]
Laboratory literature summary: The significance of vasoactive intestinal peptide in immunomodulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Virgolini I et al. (1995). Vasoactive intestinal peptide receptor scintigraphy [PMID: 7562036]
Laboratory literature summary: Vasoactive intestinal peptide receptor scintigraphy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li Q (1980). [Vasoactive intestinal polypeptide] [PMID: 6115467]
Laboratory literature summary: [Vasoactive intestinal polypeptide]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Smitherman TC et al. (1988). Vasoactive intestinal peptide as a coronary vasodilator [PMID: 3291697]
Laboratory literature summary: Vasoactive intestinal peptide as a coronary vasodilator. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lam KS (1991). Vasoactive intestinal peptide in the hypothalamus and pituitary [PMID: 1901391]
Laboratory literature summary: Vasoactive intestinal peptide in the hypothalamus and pituitary. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frye BC et al. (2020). Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis [PMID: 32579820]
Laboratory literature summary: Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Voice JK et al. (2002). Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide [PMID: 12409234]
Laboratory literature summary: Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J (1993). Transmitter role of vasoactive intestinal peptide [PMID: 8103215]
Laboratory literature summary: Transmitter role of vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Reichlin S (1988). Neuroendocrine significance of vasoactive intestinal polypeptide [PMID: 2898911]
Laboratory literature summary: Neuroendocrine significance of vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Smith SL et al. (2002). Pheochromocytoma producing vasoactive intestinal peptide [PMID: 11795252]
Laboratory literature summary: Pheochromocytoma producing vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li C et al. (2018). Role of vasoactive intestinal peptide in Aspergillus fumigatus-infected cornea [PMID: 29487804]
Laboratory literature summary: Role of vasoactive intestinal peptide in Aspergillus fumigatus-infected cornea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Baraniuk JN et al. (1990). Vasoactive intestinal peptide in research subjects nasal mucosa [PMID: 2203825]
Laboratory literature summary: Vasoactive intestinal peptide in research subjects nasal mucosa. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Arranz A et al. (2008). Laboratory research record on VIP (Vasoactive Intestinal ) [PMID: 18667799]
PubMed laboratory record discussing VIP (Vasoactive Intestinal ) in a research context. Review the full methods and limitations on PubMed; research use only.
Li B et al. (2019). Investigational effect of vasoactive intestinal peptide on form-deprived amblyopic kittens [PMID: 31429729]
Laboratory literature summary: investigational effect of vasoactive intestinal peptide on form-deprived amblyopic kittens. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mutt V (1988). Vasoactive intestinal polypeptide and related peptides. Isolation and chemistry [PMID: 3133967]
Laboratory literature summary: Vasoactive intestinal polypeptide and related peptides. Isolation and chemistry. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Delgado M et al. (1999). Vasoactive intestinal peptide in thymus: synthesis, receptors and biological actions [PMID: 9876240]
Laboratory literature summary: Vasoactive intestinal peptide in thymus: synthesis, receptors and biological actions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ottesen B (1983). Vasoactive intestinal polypeptide as a neurotransmitter in the research models genital… [PMID: 6137145]
Laboratory literature summary: Vasoactive intestinal polypeptide as a neurotransmitter in the research models genital tract. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Khedr MEMS et al. (2018). Vasoactive intestinal peptide induces proliferation of research subjects hepatocytes [PMID: 30028555]
Laboratory literature summary: Vasoactive intestinal peptide induces proliferation of research subjects hepatocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Stone RA (1986). Vasoactive intestinal polypeptide and the ocular innervation [PMID: 3710734]
Laboratory literature summary: Vasoactive intestinal polypeptide and the ocular innervation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Burleigh DE et al. (2007). Stimulation of intestinal secretion by vasoactive intestinal peptide and cholera toxin [PMID: 17023221]
Laboratory literature summary: Stimulation of intestinal secretion by vasoactive intestinal peptide and cholera toxin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alessandrini F et al. (1993). Vasoactive intestinal peptide enhances lung preservation [PMID: 8212221]
Laboratory literature summary: Vasoactive intestinal peptide enhances lung preservation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brenneman DE et al. (1999). Vasoactive intestinal peptide. Link between electrical activity and glia-mediated… [PMID: 10676432]
Laboratory literature summary: Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophism. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sharpless NS et al. (1984). Vasoactive intestinal peptide in cerebrospinal fluid [PMID: 6473166]
Laboratory literature summary: Vasoactive intestinal peptide in cerebrospinal fluid. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Piggins HD et al. (2003). The roles of vasoactive intestinal polypeptide in the mammalian circadian clock [PMID: 12697032]
Laboratory literature summary: The roles of vasoactive intestinal polypeptide in the mammalian circadian clock. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kodali S et al. (2004). Vasoactive intestinal peptide modulates Langerhans cell immune function [PMID: 15528344]
Laboratory literature summary: Vasoactive intestinal peptide modulates Langerhans cell immune function. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Barrowcliffe MP et al. (1986). Pulmonary clearance of vasoactive intestinal peptide [PMID: 3010486]
Laboratory literature summary: Pulmonary clearance of vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gonzalez-Rey E et al. (2007). Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator [PMID: 17430175]
Laboratory literature summary: Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bloom SR et al. (1973). Vasoactive intestinal peptide and watery-diarrhoea syndrome [PMID: 4123289]
Laboratory literature summary: Vasoactive intestinal peptide and watery-diarrhoea syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grider JR et al. (1988). Vasoactive intestinal peptide. Transmitter of inhibitory motor neurons of the gut [PMID: 2898909]
Laboratory literature summary: Vasoactive intestinal peptide. Transmitter of inhibitory motor neurons of the gut. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gressens P (1998). [Vasoactive intestinal peptide: a novel neurotrophic factor] [PMID: 9759212]
Laboratory literature summary: [Vasoactive intestinal peptide: a novel neurotrophic factor]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dorsam GP et al. (2011). Vasoactive intestinal peptide signaling axis in research subjects leukemia [PMID: 21765981]
Laboratory literature summary: Vasoactive intestinal peptide signaling axis in research subjects leukemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gerhold LM et al. (2001). Vasoactive intestinal peptide fibers innervate neuroendocrine dopaminergic neurons [PMID: 11689162]
Laboratory literature summary: Vasoactive intestinal peptide fibers innervate neuroendocrine dopaminergic neurons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zudenigo D et al. (1989). [Vasoactive intestinal polypeptide: a potential neurotransmitter] [PMID: 2576679]
Laboratory literature summary: [Vasoactive intestinal polypeptide: a potential neurotransmitter]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cooney DR et al. (1982). Vasoactive intestinal peptide producing neuroblastoma [PMID: 6298396]
Laboratory literature summary: Vasoactive intestinal peptide producing neuroblastoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kimata H (1996). Vasoactive intestinal peptide differentially modulates research subjects… [PMID: 8790785]
Laboratory literature summary: Vasoactive intestinal peptide differentially modulates research subjects immunoglobulin production. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bodanszky M (1988). Synthesis of vasoactive intestinal peptide and related peptides [PMID: 3291693]
Laboratory literature summary: Synthesis of vasoactive intestinal peptide and related peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Buchan AM et al. (1981). Vasoactive intestinal polypeptide (VIP)-like immunoreactivity in anuran intestine [PMID: 6784927]
Laboratory literature summary: Vasoactive intestinal polypeptide (VIP)-like immunoreactivity in anuran intestine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hokari R et al. (2005). Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1 [PMID: 16227528]
Laboratory literature summary: Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Marpegan L et al. (2009). Vasoactive intestinal polypeptide entrains circadian rhythms in astrocytes [PMID: 19346450]
Laboratory literature summary: Vasoactive intestinal polypeptide entrains circadian rhythms in astrocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bissonnette BM et al. (1984). Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini [PMID: 6204536]
Laboratory literature summary: Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Misra BR et al. (1990). Vasoactive intestinal peptide, a singlet oxygen quencher [PMID: 2168410]
Laboratory literature summary: Vasoactive intestinal peptide, a singlet oxygen quencher. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bloom SR et al. (1976). Letter: Vasoactive intestinal polypeptide [PMID: 59264]
Laboratory literature summary: Letter: Vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lygren I et al. (1984). Vasoactive intestinal polypeptide and somatostatin in leucocytes [PMID: 6147010]
Laboratory literature summary: Vasoactive intestinal polypeptide and somatostatin in leucocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1988). Vasoactive intestinal polypeptide and the reproductive system [PMID: 3291695]
Laboratory literature summary: Vasoactive intestinal polypeptide and the reproductive system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brenneman DE et al. (1986). Vasoactive intestinal peptide and electrical activity influence neuronal survival [PMID: 3456568]
Laboratory literature summary: Vasoactive intestinal peptide and electrical activity influence neuronal survival. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Loh DH et al. (2008). Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoids [PMID: 18562786]
Laboratory literature summary: Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoids. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hawley CM et al. (1991). Oral sodium regulates extrahepatic metabolism of vasoactive intestinal peptide [PMID: 1649728]
Laboratory literature summary: Oral sodium regulates extrahepatic metabolism of vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grider JR et al. (1987). Prejunctional inhibition of vasoactive intestinal peptide release [PMID: 3605338]
Laboratory literature summary: Prejunctional inhibition of vasoactive intestinal peptide release. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Korleski J et al. (2026). Elevated vasoactive intestinal peptide concentrations poorly predict VIPoma [PMID: 41498509]
Laboratory literature summary: Elevated vasoactive intestinal peptide concentrations poorly predict VIPoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sundler F et al. (1988). Vasoactive intestinal peptide in the peripheral nervous system [PMID: 3291690]
Laboratory literature summary: Vasoactive intestinal peptide in the peripheral nervous system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wilson DA et al. (1981). Vasoactive intestinal polypeptide and the canine cerebral circulation [PMID: 7438343]
Laboratory literature summary: Vasoactive intestinal polypeptide and the canine cerebral circulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (2012). Vasoactive intestinal peptide in pulmonary arterial hypertension [PMID: 22467806]
Laboratory literature summary: Vasoactive intestinal peptide in pulmonary arterial hypertension. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Revhaug A et al. (1988). Vasoactive intestinal peptide in sepsis and shock [PMID: 3291700]
Laboratory literature summary: Vasoactive intestinal peptide in sepsis and shock. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
O'Dorisio MS et al. (1992). Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma [PMID: 1313595]
Laboratory literature summary: Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rostene W et al. (1997). Steroid Regulation of Vasoactive Intestinal Peptide (VIP) [PMID: 9787257]
Laboratory literature summary: Steroid Regulation of Vasoactive Intestinal Peptide (VIP). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mácsai M et al. (1998). Vasoactive intestinal polypeptide induces analgesia and impairs the antinociceptive… [PMID: 9920454]
Laboratory literature summary: Vasoactive intestinal polypeptide induces analgesia and impairs the antinociceptive effect of morphine in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bolin DR (1993). Vasoactive intestinal peptide: role of calmodulin and catalytic antibodies [PMID: 8220168]
Laboratory literature summary: Vasoactive intestinal peptide: role of calmodulin and catalytic antibodies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hultgårdh-Nilsson A et al. (1988). Growth-inhibitory properties of vasoactive intestinal polypeptide [PMID: 2902657]
Laboratory literature summary: Growth-inhibitory properties of vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Doi R et al. (2006). [Vasoactive intestinal peptide-producing oncology research models (ViPoma)] [PMID: 17022564]
Laboratory literature summary: [Vasoactive intestinal peptide-producing oncology research models (ViPoma)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Onyüksel H et al. (2000). Surface-active properties of vasoactive intestinal peptide* [PMID: 10793226]
Laboratory literature summary: Surface-active properties of vasoactive intestinal peptide*. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mei S et al. (1991). Vasoactive intestinal peptide hydrolysis by antibody light chains [PMID: 1908455]
Laboratory literature summary: Vasoactive intestinal peptide hydrolysis by antibody light chains. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rahmann A et al. (2008). Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce… [PMID: 18254893]
Laboratory literature summary: Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Aton SJ et al. (2005). Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in… [PMID: 15750589]
Laboratory literature summary: Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Duggan KA et al. (1987). Vasoactive intestinal peptide: a direct renal natriuretic substance [PMID: 3816077]
Laboratory literature summary: Vasoactive intestinal peptide: a direct renal natriuretic substance. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pincelli C et al. (1991). Skin levels of vasoactive intestinal polypeptide in atopic dermatitis [PMID: 1929540]
Laboratory literature summary: Skin levels of vasoactive intestinal polypeptide in atopic dermatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Metwali A et al. (2002). IL-4 inhibits vasoactive intestinal peptide production by macrophages [PMID: 12065298]
Laboratory literature summary: IL-4 inhibits vasoactive intestinal peptide production by macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhuo ZH et al. (2009). [Vasoactive intestinal peptidoma in a child] [PMID: 19573420]
Laboratory literature summary: [Vasoactive intestinal peptidoma in a child]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1993). Vasoactive intestinal peptide: involvement of calmodulin and catalytic antibodies [PMID: 8220167]
Laboratory literature summary: Vasoactive intestinal peptide: involvement of calmodulin and catalytic antibodies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI et al. (1979). Vasoactive intestinal polypeptide: release into hypophyseal portal blood [PMID: 423700]
Laboratory literature summary: Vasoactive intestinal polypeptide: release into hypophyseal portal blood. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gonzalez-Rey E et al. (2005). Role of vasoactive intestinal peptide in inflammation and autoimmunity [PMID: 16312132]
Laboratory literature summary: Role of vasoactive intestinal peptide in inflammation and autoimmunity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rosselin G et al. (1988). Regulation of the vasoactive intestinal peptide receptor [PMID: 2839078]
Laboratory literature summary: Regulation of the vasoactive intestinal peptide receptor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ottaway CA (1988). Vasoactive intestinal peptide as a modulator of lymphocyte and immune function [PMID: 2839085]
Laboratory literature summary: Vasoactive intestinal peptide as a modulator of lymphocyte and immune function. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ganz P et al. (1986). Vasoactive intestinal peptide: vasodilatation and cyclic AMP generation [PMID: 3010741]
Laboratory literature summary: Vasoactive intestinal peptide: vasodilatation and cyclic AMP generation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Paul S et al. (1993). Vasoactive intestinal peptide: its interactions with calmodulin and catalytic antibodies [PMID: 8220166]
Laboratory literature summary: Vasoactive intestinal peptide: its interactions with calmodulin and catalytic antibodies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mohney RP et al. (1998). Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after… [PMID: 9651211]
Laboratory literature summary: Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Elias E et al. (1975). Letter: Vasoactive intestinal peptide in cirrhosis [PMID: 54837]
Laboratory literature summary: Letter: Vasoactive intestinal peptide in cirrhosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (1999). Vasoactive intestinal peptide/phentolamine. Invicorp, vasopotin [PMID: 10763461]
Laboratory literature summary: Vasoactive intestinal peptide/phentolamine. Invicorp, vasopotin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hansen JM et al. (2006). Vasoactive intestinal polypeptide evokes only a minimal headache in healthy research… [PMID: 16886936]
Laboratory literature summary: Vasoactive intestinal polypeptide evokes only a minimal headache in healthy research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grider JR et al. (1985). Vasoactive intestinal peptide as a neural mediator of gastric relaxation [PMID: 3966563]
Laboratory literature summary: Vasoactive intestinal peptide as a neural mediator of gastric relaxation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tecza K et al. (2026). Vasoactive intestinal peptide advances chondrogenesis and modulates pathogenic… [PMID: 42178419]
Laboratory literature summary: Vasoactive intestinal peptide advances chondrogenesis and modulates pathogenic mediators in research subjects osteoarthritis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Leuchte HH et al. (2008). Inhalation of vasoactive intestinal peptide in pulmonary hypertension [PMID: 18978135]
Laboratory literature summary: Inhalation of vasoactive intestinal peptide in pulmonary hypertension. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tomkin GH et al. (1983). Vasoactive intestinal polypeptide in metabolic research models [PMID: 6345422]
Laboratory literature summary: Vasoactive intestinal polypeptide in metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Aggestrup S et al. (1983). Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia [PMID: 6832568]
Laboratory literature summary: Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Varsky CG (1978). [Vasoactive intestinal polypeptide (V.I.P)] [PMID: 33518]
Laboratory literature summary: [Vasoactive intestinal polypeptide (V.I.P)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sung KJ et al. (1999). Vasoactive intestinal polypeptide stimulates the proliferation of HaCaT cell via TGF-alpha [PMID: 10657522]
Laboratory literature summary: Vasoactive intestinal polypeptide stimulates the proliferation of HaCaT cell via TGF-alpha. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nyberg B et al. (1989). Evidence that vasoactive intestinal peptide induces ductular secretion of bile in… [PMID: 2914652]
Laboratory literature summary: Evidence that vasoactive intestinal peptide induces ductular secretion of bile in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Maggi CA et al. (1995). Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the… [PMID: 7724664]
Laboratory literature summary: Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mathioudakis A et al. (2013). Vasoactive intestinal Peptide inhaled agonists: potential role in respiratory therapeutics [PMID: 23935337]
Laboratory literature summary: Vasoactive intestinal Peptide inhaled agonists: potential role in respiratory therapeutics. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Takeyama M et al. (1996). Elcatonin raises levels of vasoactive intestinal peptide in research subjects plasma [PMID: 8832504]
Laboratory literature summary: Elcatonin raises levels of vasoactive intestinal peptide in research subjects plasma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Barnes PJ (1989). Vasoactive intestinal peptide and asthma [PMID: 2797074]
Laboratory literature summary: Vasoactive intestinal peptide and asthma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cugini P et al. (1991). Vasoactive intestinal peptide: a chronoimmunomodulator? [PMID: 1782019]
Laboratory literature summary: Vasoactive intestinal peptide: a chronoimmunomodulator?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chard MD et al. (1990). Vasoactive intestinal polypeptide in algodystrophy [PMID: 2257465]
Laboratory literature summary: Vasoactive intestinal polypeptide in algodystrophy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chorny A et al. (2006). Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions [PMID: 16949684]
Laboratory literature summary: Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Souza-Moreira L et al. (2012). Laboratory research record on VIP (Vasoactive Intestinal ) [PMID: 23094830]
PubMed laboratory record discussing VIP (Vasoactive Intestinal ) in a research context. Review the full methods and limitations on PubMed; research use only.
Ottesen B et al. (1984). Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter [PMID: 6140066]
Laboratory literature summary: Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Delgado M et al. (2005). The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells [PMID: 16301637]
Laboratory literature summary: The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Campos-Salinas J et al. (2014). Investigational observed endpoints of stable analogues of vasoactive intestinal… [PMID: 24706753]
Laboratory literature summary: investigational observed endpoints of stable analogues of vasoactive intestinal peptide against pathogens. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gozes I et al. (1989). Vasoactive intestinal peptide potentiates behavioral behavior: inhibition by novel… [PMID: 2583049]
Laboratory literature summary: Vasoactive intestinal peptide potentiates behavioral behavior: inhibition by novel antagonist. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Matsumura M et al. (1979). Effects of vasoactive intestinal peptide on glycogenolysis in cultured liver cells [PMID: 477614]
Laboratory literature summary: Effects of vasoactive intestinal peptide on glycogenolysis in cultured liver cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Burhol PG et al. (1978). Radioimmunoassay of vasoactive intestinal polypeptide in plasma [PMID: 725503]
Laboratory literature summary: Radioimmunoassay of vasoactive intestinal polypeptide in plasma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lopez-Sánchez G et al. (2016). [Adrenal pheochromocytoma producing vasoactive intestinal peptide] [PMID: 26520602]
Laboratory literature summary: [Adrenal pheochromocytoma producing vasoactive intestinal peptide]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ebeid AM et al. (1978). Hepatic inactivation of vasoactive intestinal peptide in man and dog [PMID: 666373]
Laboratory literature summary: Hepatic inactivation of vasoactive intestinal peptide in man and dog. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Krejs GJ (1988). Effect of vasoactive intestinal peptide in man [PMID: 2839086]
Laboratory literature summary: Effect of vasoactive intestinal peptide in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Harrison LH Jr et al. (1985). Vasoactive intestinal polypeptide in cardiac myxoma [PMID: 3990331]
Laboratory literature summary: Vasoactive intestinal polypeptide in cardiac myxoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Prasse A et al. (2010). Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis [PMID: 20442436]
Laboratory literature summary: Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hajos F et al. (2008). Inhalable liposomal formulation for vasoactive intestinal peptide [PMID: 18328650]
Laboratory literature summary: Inhalable liposomal formulation for vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chang TM et al. (1979). Radioimmunoassay of vasoactive intestinal polypeptide [PMID: 525792]
Laboratory literature summary: Radioimmunoassay of vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gourlet P et al. (1998). Vasoactive intestinal peptide modification at position 22 allows discrimination… [PMID: 9650836]
Laboratory literature summary: Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Swedlund AP et al. (1990). Characterization of vasoactive intestinal peptide receptors in retina [PMID: 2169429]
Laboratory literature summary: Characterization of vasoactive intestinal peptide receptors in retina. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Soon-Shiong P et al. (1981). Non-vasoactive intestinal polypeptide, nonsomatostatin fundic inhibitoy mechanism [PMID: 6113305]
Laboratory literature summary: Non-vasoactive intestinal polypeptide, nonsomatostatin fundic inhibitoy mechanism. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Stadelmann AM et al. (1996). Expression of mRNA for vasoactive intestinal peptide in rat small intestine [PMID: 8822262]
Laboratory literature summary: Expression of mRNA for vasoactive intestinal peptide in rat small intestine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (1988). Vasoactive intestinal peptide and related peptides [PMID: 3389646]
Laboratory literature summary: Vasoactive intestinal peptide and related peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1991). Vasoactive intestinal polypeptide: biologic role in health and disease [PMID: 18411175]
Laboratory literature summary: Vasoactive intestinal polypeptide: biologic role in health and disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rattan S et al. (1977). Effect of vasoactive intestinal polypeptide [PMID: 859880]
Laboratory literature summary: Effect of vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Taylor DP et al. (1979). Vasoactive intestinal polypeptide: specific binding to rat brain membranes [PMID: 218214]
Laboratory literature summary: Vasoactive intestinal polypeptide: specific binding to rat brain membranes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rattan S et al. (1982). Vasoactive intestinal peptide causes peristaltic contractions in the esophageal body [PMID: 7078354]
Laboratory literature summary: Vasoactive intestinal peptide causes peristaltic contractions in the esophageal body. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
De Souza EB et al. (1985). Vasoactive intestinal peptide receptor localization in rat forebrain by autoradiography [PMID: 2989737]
Laboratory literature summary: Vasoactive intestinal peptide receptor localization in rat forebrain by autoradiography. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Basson MD et al. (1989). Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction? [PMID: 2910115]
Laboratory literature summary: Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shinohara K et al. (1995). Photic information coded by vasoactive intestinal polypeptide and neuropeptide Y [PMID: 7566737]
Laboratory literature summary: Photic information coded by vasoactive intestinal polypeptide and neuropeptide Y. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kulkosky PJ et al. (1989). Vasoactive intestinal peptide: behavioral effects in the rat and hamster [PMID: 2622995]
Laboratory literature summary: Vasoactive intestinal peptide: behavioral effects in the rat and hamster. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rayan GM et al. (1991). Vasoactive intestinal peptide and nerve regeneration [PMID: 1791362]
Laboratory literature summary: Vasoactive intestinal peptide and nerve regeneration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
O'Dorisio MS et al. (1981). Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase [PMID: 6975328]
Laboratory literature summary: Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lundeberg L et al. (1999). Vasoactive intestinal polypeptide in allergic contact dermatitis: an… [PMID: 10335916]
Laboratory literature summary: Vasoactive intestinal polypeptide in allergic contact dermatitis: an immunohistochemical and radioimmunoassay study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Domschke S et al. (1978). Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects [PMID: 730072]
Laboratory literature summary: Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kusunoki M et al. (1986). Vasoactive intestinal polypeptide provokes acetylcholine release from the myenteric plexus [PMID: 3728677]
Laboratory literature summary: Vasoactive intestinal polypeptide provokes acetylcholine release from the myenteric plexus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grisoni E et al. (1993). Vasoactive intestinal polypeptide causes relaxation of the pyloric sphincter in the rabbit [PMID: 8308673]
Laboratory literature summary: Vasoactive intestinal polypeptide causes relaxation of the pyloric sphincter in the rabbit. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Paul S et al. (1989). Catalytic hydrolysis of vasoactive intestinal peptide by research subjects autoantibody [PMID: 2727702]
Laboratory literature summary: Catalytic hydrolysis of vasoactive intestinal peptide by research subjects autoantibody. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Biancani P et al. (1984). Vasoactive intestinal polypeptide. A neurotransmitter for lower esophageal sphincter… [PMID: 6142903]
Laboratory literature summary: Vasoactive intestinal polypeptide. A neurotransmitter for lower esophageal sphincter relaxation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Noda Y et al. (1994). Partitioning of vasoactive intestinal polypeptide into lipid bilayers [PMID: 8172918]
Laboratory literature summary: Partitioning of vasoactive intestinal polypeptide into lipid bilayers. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Williams RO (2002). Investigational effect of vasoactive intestinal peptide in collagen-induced arthritis [PMID: 11817602]
Laboratory literature summary: investigational effect of vasoactive intestinal peptide in collagen-induced arthritis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grisoni ER et al. (1990). Plasma vasoactive intestinal polypeptide in the newborn infant [PMID: 2303969]
Laboratory literature summary: Plasma vasoactive intestinal polypeptide in the newborn infant. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Giachetti A et al. (1976). Vasoactive intestinal polypeptide in brain synaptosomes [PMID: 61421]
Laboratory literature summary: Vasoactive intestinal polypeptide in brain synaptosomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rayan GM et al. (1988). Vasoactive intestinal peptide and compression neuropathy [PMID: 3347676]
Laboratory literature summary: Vasoactive intestinal peptide and compression neuropathy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
O'Dorisio MS et al. (1980). Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes [PMID: 6932456]
Laboratory literature summary: Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pence JC et al. (1992). Autoregulation of neuroblastoma growth by vasoactive intestinal peptide [PMID: 1328588]
Laboratory literature summary: Autoregulation of neuroblastoma growth by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kordasti S et al. (2004). Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea [PMID: 15194642]
Laboratory literature summary: Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Davis RE et al. (1995). Vasoactive intestinal peptide regulates angiotensin II catabolism in the rabbit [PMID: 7625178]
Laboratory literature summary: Vasoactive intestinal peptide regulates angiotensin II catabolism in the rabbit. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bangale Y et al. (2002). Vasoactive intestinal peptide binding autoantibodies in autoimmune research subjects… [PMID: 12535706]
Laboratory literature summary: Vasoactive intestinal peptide binding autoantibodies in autoimmune research subjects and mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ebeid AM et al. (1976). Radioimmunoassay of vasoactive intestinal peptide [PMID: 933489]
Laboratory literature summary: Radioimmunoassay of vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chaudhury D et al. (2008). Select cognitive deficits in vasoactive intestinal peptide deficient mice [PMID: 18616823]
Laboratory literature summary: Select cognitive deficits in vasoactive intestinal peptide deficient mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kiely EA et al. (1986). Vasoactive intestinal polypeptide during penile erection [PMID: 2871266]
Laboratory literature summary: Vasoactive intestinal polypeptide during penile erection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li GH et al. (2007). Effect of vasoactive intestinal peptide on gastric adenocarcinoma [PMID: 17559364]
Laboratory literature summary: Effect of vasoactive intestinal peptide on gastric adenocarcinoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wikkelsø C et al. (1985). Dementia of different etiologies: vasoactive intestinal polypeptide in CSF [PMID: 3982653]
Laboratory literature summary: Dementia of different etiologies: vasoactive intestinal polypeptide in CSF. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sharma A et al. (2001). A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells [PMID: 11859929]
Laboratory literature summary: A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rukwied R et al. (1999). Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema… [PMID: 10206720]
Laboratory literature summary: Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
DeLamarter JF et al. (1985). Vasoactive intestinal peptide: expression of the prohormone in bacterial cells [PMID: 2995945]
Laboratory literature summary: Vasoactive intestinal peptide: expression of the prohormone in bacterial cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pulsatelli L et al. (2006). Synovial expression of vasoactive intestinal peptide in polymyalgia rheumatica [PMID: 17181926]
Laboratory literature summary: Synovial expression of vasoactive intestinal peptide in polymyalgia rheumatica. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kan S et al. (1994). Specific receptor for vasoactive intestinal contractor in myenteric cholinergic neurones [PMID: 7925592]
Laboratory literature summary: Specific receptor for vasoactive intestinal contractor in myenteric cholinergic neurones. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wernig K et al. (2008). Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable… [PMID: 18601963]
Laboratory literature summary: Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kuncová J et al. (2000). Vasoactive intestinal polypeptide in rat heart atria: the effect of hyperthyroidism [PMID: 11072802]
Laboratory literature summary: Vasoactive intestinal polypeptide in rat heart atria: the effect of hyperthyroidism. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ivanova M et al. (2008). Hippocampal asymmetry in exploratory behavior to vasoactive intestinal polypeptide [PMID: 18321609]
Laboratory literature summary: Hippocampal asymmetry in exploratory behavior to vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kato Y et al. (1978). Prolactin release by vasoactive intestinal polypeptide in rats [PMID: 744101]
Laboratory literature summary: Prolactin release by vasoactive intestinal polypeptide in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Larsson LI (1976). Research subjects pancreatic polypeptide and vasoactive intestinal polypeptide [PMID: 73783]
Laboratory literature summary: research subjects pancreatic polypeptide and vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hansson E et al. (1988). Interaction between catecholamines and vasoactive intestinal peptide in cultured… [PMID: 2836754]
Laboratory literature summary: Interaction between catecholamines and vasoactive intestinal peptide in cultured astrocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kim DH et al. (2011). Alterations of vasoactive intestinal polypeptide receptors in allergic rhinitis [PMID: 21711977]
Laboratory literature summary: Alterations of vasoactive intestinal polypeptide receptors in allergic rhinitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Stone RA et al. (1988). Increase in retinal vasoactive intestinal polypeptide after eyelid fusion in primates [PMID: 2448769]
Laboratory literature summary: Increase in retinal vasoactive intestinal polypeptide after eyelid fusion in primates. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cugini P et al. (1991). Vasoactive intestinal peptide fluctuates in research subjects blood with a circadian… [PMID: 1924885]
Laboratory literature summary: Vasoactive intestinal peptide fluctuates in research subjects blood with a circadian rhythm. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chiodera P et al. (1998). Oxytocin enhances the prolactin response to vasoactive intestinal polypeptide in… [PMID: 9757887]
Laboratory literature summary: Oxytocin enhances the prolactin response to vasoactive intestinal polypeptide in healthy research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schwarzschild MA et al. (1989). Secretin and vasoactive intestinal peptide activate tyrosine hydroxylase in… [PMID: 2563276]
Laboratory literature summary: Secretin and vasoactive intestinal peptide activate tyrosine hydroxylase in sympathetic nerve endings. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1979). Vasoactive intestinal polypeptide in vagally mediated pancreatic secretion of fluid… [PMID: 517650]
Laboratory literature summary: Vasoactive intestinal polypeptide in vagally mediated pancreatic secretion of fluid and HCO3. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brenneman DE et al. (1990). Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen [PMID: 2325164]
Laboratory literature summary: Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brenneman DE et al. (1997). Identity of neurotrophic molecules released from astroglia by vasoactive intestinal… [PMID: 9160969]
Laboratory literature summary: Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tyutyulkova S et al. (1996). Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains… [PMID: 8781541]
Laboratory literature summary: Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains selected by phage display. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dupont C et al. (1985). [Vasoactive intestinal peptide: a ubiquitous neuropeptide. Implications in digestive… [PMID: 2867748]
Laboratory literature summary: [Vasoactive intestinal peptide: a ubiquitous neuropeptide. Implications in digestive physiopathology]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Morice AH et al. (1986). Vasoactive intestinal peptide as a bronchodilator in severe asthma [PMID: 3529052]
Laboratory literature summary: Vasoactive intestinal peptide as a bronchodilator in severe asthma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Virag R et al. (1982). Vasoactive intestinal polypeptide release during penile erection in man [PMID: 6128487]
Laboratory literature summary: Vasoactive intestinal polypeptide release during penile erection in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wessels-Reiker M et al. (1991). Vasoactive intestinal polypeptide induces tyrosine hydroxylase in PC12 cells [PMID: 1674510]
Laboratory literature summary: Vasoactive intestinal polypeptide induces tyrosine hydroxylase in PC12 cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rosas G et al. (2015). Asymmetric steroidogenic response by the ovaries to the vasoactive intestinal peptide [PMID: 25331816]
Laboratory literature summary: Asymmetric steroidogenic response by the ovaries to the vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kimura H et al. (1994). Vasoactive intestinal peptide released by acetylcholine in the dog ileum [PMID: 8089398]
Laboratory literature summary: Vasoactive intestinal peptide released by acetylcholine in the dog ileum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
O'Donnell M et al. (1991). Structure-activity studies of vasoactive intestinal polypeptide [PMID: 1848854]
Laboratory literature summary: Structure-activity studies of vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Leoni G et al. (2000). Vasoactive intestinal peptide influences hatching of ovine blastocysts [PMID: 11194560]
Laboratory literature summary: Vasoactive intestinal peptide influences hatching of ovine blastocysts. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Contreras LN et al. (1991). Adrenal ganglioneuroma-pheochromocytoma secreting vasoactive intestinal polypeptide [PMID: 2028605]
Laboratory literature summary: Adrenal ganglioneuroma-pheochromocytoma secreting vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Thulin L et al. (1976). Choleretic effect of vasoactive intestinal peptide [PMID: 936953]
Laboratory literature summary: Choleretic effect of vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lorén I et al. (1979). Distribution of vasoactive intestinal polypeptide in the rat and mouse brain [PMID: 394023]
Laboratory literature summary: Distribution of vasoactive intestinal polypeptide in the rat and mouse brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Taniyama K et al. (1993). Involvement of cholinergic neurons in intestinal contraction caused by vasoactive… [PMID: 8519276]
Laboratory literature summary: Involvement of cholinergic neurons in intestinal contraction caused by vasoactive intestinal contractor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Werner H et al. (1985). High levels of vasoactive intestinal peptide in research subjects milk [PMID: 4074363]
Laboratory literature summary: High levels of vasoactive intestinal peptide in research subjects milk. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ipp E et al. (1978). Vasoactive intestinal peptide stimulates pancreatic somatostatin release [PMID: 350630]
Laboratory literature summary: Vasoactive intestinal peptide stimulates pancreatic somatostatin release. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Azuero-Holguin MM et al. (2003). Identification and quantification of vasoactive intestinal peptide in periradicular… [PMID: 14503825]
Laboratory literature summary: Identification and quantification of vasoactive intestinal peptide in periradicular lesions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ghourab S et al. (2011). Intracerebroventricular administration of vasoactive intestinal peptide inhibits food… [PMID: 21802451]
Laboratory literature summary: Intracerebroventricular administration of vasoactive intestinal peptide inhibits food intake. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Paul S et al. (1995). Catalytic autoantibodies to vasoactive intestinal peptide [PMID: 7874991]
Laboratory literature summary: Catalytic autoantibodies to vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frase LL et al. (1987). Cardiovascular effects of vasoactive intestinal peptide in healthy subjects [PMID: 3687785]
Laboratory literature summary: Cardiovascular effects of vasoactive intestinal peptide in healthy subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Burleigh DE et al. (1990). Distribution and actions of galanin and vasoactive intestinal peptide in the research… [PMID: 1701228]
Laboratory literature summary: Distribution and actions of galanin and vasoactive intestinal peptide in the research subjects colon. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brenneman DE et al. (1987). Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide [PMID: 3584242]
Laboratory literature summary: Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Paul S (1989). Decreased selectivity of vasoactive intestinal peptide receptors by GTP [PMID: 2537088]
Laboratory literature summary: Decreased selectivity of vasoactive intestinal peptide receptors by GTP. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cunha-Reis D et al. (2014). Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal… [PMID: 24935659]
Laboratory literature summary: Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bitar KN et al. (1980). Neural release of vasoactive intestinal peptide from the gut [PMID: 7439634]
Laboratory literature summary: Neural release of vasoactive intestinal peptide from the gut. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Filizola M et al. (1997). Conformational study of vasoactive intestinal peptide by computational methods [PMID: 9273888]
Laboratory literature summary: Conformational study of vasoactive intestinal peptide by computational methods. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kawano H et al. (1989). Do the ependymal cells contain vasoactive intestinal polypeptide? [PMID: 2601880]
Laboratory literature summary: Do the ependymal cells contain vasoactive intestinal polypeptide?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Paul S et al. (1989). Characterization of autoantibodies to vasoactive intestinal peptide in asthma [PMID: 2542371]
Laboratory literature summary: Characterization of autoantibodies to vasoactive intestinal peptide in asthma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Phillis JW et al. (1978). Vasoactive intestinal polypeptide excitation of central neurons [PMID: 416895]
Laboratory literature summary: Vasoactive intestinal polypeptide excitation of central neurons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
El-Halawani ME et al. (2000). Active immunization with vasoactive intestinal peptide in turkey hens [PMID: 10735201]
Laboratory literature summary: Active immunization with vasoactive intestinal peptide in turkey hens. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kaneto A et al. (1977). Effect of vasoactive intestinal polypeptide infused intrapancreatically on glucagon… [PMID: 865285]
Laboratory literature summary: Effect of vasoactive intestinal polypeptide infused intrapancreatically on glucagon and insulin secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pinna C et al. (1998). ATP and vasoactive intestinal polypeptide relaxant responses in hamster isolated… [PMID: 9720775]
Laboratory literature summary: ATP and vasoactive intestinal polypeptide relaxant responses in hamster isolated proximal urethra. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hunt S et al. (1979). Circulating levels of vasoactive intestinal polypeptide in liver disease [PMID: 475538]
Laboratory literature summary: Circulating levels of vasoactive intestinal polypeptide in liver disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hedlund B et al. (1988). Vasoactive intestinal polypeptide alters GH3/B6 pituitary cell excitability [PMID: 3357755]
Laboratory literature summary: Vasoactive intestinal polypeptide alters GH3/B6 pituitary cell excitability. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Misawa T et al. (1990). Vasoactive intestinal polypeptide response to ethanol in dogs [PMID: 2396256]
Laboratory literature summary: Vasoactive intestinal polypeptide response to ethanol in dogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Van Noorden S et al. (1979). Vasoactive intestinal polypeptide in the neurohypophysis [proceedings] [PMID: 458317]
Laboratory literature summary: Vasoactive intestinal polypeptide in the neurohypophysis [proceedings]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lothe L et al. (1987). Motilin, vasoactive intestinal peptide and gastrin in infantile colic [PMID: 3591297]
Laboratory literature summary: Motilin, vasoactive intestinal peptide and gastrin in infantile colic. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dimaline R et al. (1984). Isolation and characterization of rat vasoactive intestinal peptide [PMID: 6473151]
Laboratory literature summary: Isolation and characterization of rat vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chaiseha Y et al. (1998). Vasoactive intestinal peptide secretion by turkey hypothalamic explants [PMID: 9716568]
Laboratory literature summary: Vasoactive intestinal peptide secretion by turkey hypothalamic explants. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gozes I et al. (1995). Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide… [PMID: 7714762]
Laboratory literature summary: Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Carlquist M et al. (1982). A porcine brain polypeptide is identical to the vasoactive intestinal polypeptide [PMID: 7084607]
Laboratory literature summary: A porcine brain polypeptide is identical to the vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zdrojewicz Z et al. (1999). [The role of vasoactive intestinal peptide in research subjects body] [PMID: 10540588]
Laboratory literature summary: [The role of vasoactive intestinal peptide in research subjects body]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gololobov G et al. (1998). Stabilization of vasoactive intestinal peptide by lipids [PMID: 9580623]
Laboratory literature summary: Stabilization of vasoactive intestinal peptide by lipids. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Accili EA et al. (1995). Presence and actions of vasoactive intestinal peptide in the isolated rabbit heart [PMID: 7541311]
Laboratory literature summary: Presence and actions of vasoactive intestinal peptide in the isolated rabbit heart. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Maney DL et al. (1999). Effects of vasoactive intestinal peptide on plasma prolactin in passerines [PMID: 10068494]
Laboratory literature summary: Effects of vasoactive intestinal peptide on plasma prolactin in passerines. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Duckles SP et al. (1982). Vasoactive intestinal peptide as a neurotransmitter in the cerebral circulation [PMID: 6121712]
Laboratory literature summary: Vasoactive intestinal peptide as a neurotransmitter in the cerebral circulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brenneman DE et al. (1996). Vasoactive intestinal peptide releases interleukin-1 from astrocytes [PMID: 8993410]
Laboratory literature summary: Vasoactive intestinal peptide releases interleukin-1 from astrocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lucia P et al. (2000). [Vasoactive intestinal peptide in heart failure] [PMID: 10834134]
Laboratory literature summary: [Vasoactive intestinal peptide in heart failure]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gaginella TS et al. (1981). Release of vasoactive intestinal polypeptide by electrical field stimulation of rabbit… [PMID: 7255769]
Laboratory literature summary: Release of vasoactive intestinal polypeptide by electrical field stimulation of rabbit ileum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brenneman DE et al. (2003). Complex array of cytokines released by vasoactive intestinal peptide [PMID: 12747943]
Laboratory literature summary: Complex array of cytokines released by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Stark B et al. (2008). Liposomal vasoactive intestinal peptide for lung application: protection from… [PMID: 18555674]
Laboratory literature summary: Liposomal vasoactive intestinal peptide for lung application: protection from proteolytic degradation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Park SK et al. (1996). Characterization of vasoactive intestinal peptide receptors on research subjects… [PMID: 8639831]
Laboratory literature summary: Characterization of vasoactive intestinal peptide receptors on research subjects megakaryocytes and platelets. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grider JR et al. (1985). Vasoactive intestinal peptide. Relaxant neurotransmitter in tenia coli of the guinea pig [PMID: 2861138]
Laboratory literature summary: Vasoactive intestinal peptide. Relaxant neurotransmitter in tenia coli of the guinea pig. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kinder RB et al. (1985). Vasoactive intestinal polypeptide in the hyper-reflexic neuropathic bladder [PMID: 4005496]
Laboratory literature summary: Vasoactive intestinal polypeptide in the hyper-reflexic neuropathic bladder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
van Noorden S et al. (1979). Vasoactive intestinal polypeptide in the pituitary pars nervosa [PMID: 471186]
Laboratory literature summary: Vasoactive intestinal polypeptide in the pituitary pars nervosa. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang R et al. (1993). Penile erections induced by vasoactive intestinal peptide and sodium nitroprusside [PMID: 8456543]
Laboratory literature summary: Penile erections induced by vasoactive intestinal peptide and sodium nitroprusside. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vagne M et al. (1982). Effect of vasoactive intestinal peptide on gastric secretion in the cat [PMID: 6806139]
Laboratory literature summary: Effect of vasoactive intestinal peptide on gastric secretion in the cat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kar S et al. (1996). Comitogenic effects of vasoactive intestinal polypeptide on rat hepatocytes [PMID: 8647908]
Laboratory literature summary: Comitogenic effects of vasoactive intestinal polypeptide on rat hepatocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Maher E et al. (1996). Laboratory research record on VIP (Vasoactive Intestinal ) [PMID: 8800898]
PubMed laboratory record discussing VIP (Vasoactive Intestinal ) in a research context. Review the full methods and limitations on PubMed; research use only.
Lindblom L et al. (2000). Importance of vasoactive intestinal polypeptide in the regulation of burn perfusion [PMID: 10812264]
Laboratory literature summary: Importance of vasoactive intestinal polypeptide in the regulation of burn perfusion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Esposito C et al. (1999). Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase [PMID: 10408336]
Laboratory literature summary: Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bunnett NW et al. (1984). The isolation and sequence analysis of vasoactive intestinal peptide from a… [PMID: 6092409]
Laboratory literature summary: The isolation and sequence analysis of vasoactive intestinal peptide from a ganglioneuroblastoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Xenopoulos NP et al. (1994). Effects of vasoactive intestinal peptide on myocardial performance [PMID: 8141340]
Laboratory literature summary: Effects of vasoactive intestinal peptide on myocardial performance. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pickoff AS et al. (1994). Vasoactive intestinal peptide: electrophysiologic activity in the newborn heart [PMID: 8165061]
Laboratory literature summary: Vasoactive intestinal peptide: electrophysiologic activity in the newborn heart. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cui X et al. (2013). Pharmacodynamics and toxicity of vasoactive intestinal peptide for intranasal… [PMID: 23444784]
Laboratory literature summary: Pharmacodynamics and toxicity of vasoactive intestinal peptide for intranasal administration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wollman Y et al. (1993). Vasoactive intestinal peptide: a growth promoter in neuroblastoma cells [PMID: 8252411]
Laboratory literature summary: Vasoactive intestinal peptide: a growth promoter in neuroblastoma cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schmid KW et al. (1993). Chromogranin A, secretogranin II and vasoactive intestinal peptide in… [PMID: 8354485]
Laboratory literature summary: Chromogranin A, secretogranin II and vasoactive intestinal peptide in phaeochromocytomas and ganglioneuromas. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Keino H et al. (2004). Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide [PMID: 15302659]
Laboratory literature summary: Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Clark AJ et al. (1983). Vasoactive intestinal peptide in shock and heart failure [PMID: 6131249]
Laboratory literature summary: Vasoactive intestinal peptide in shock and heart failure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fredericks CM et al. (1985). Vasoactive intestinal polypeptide stimulates nonovarian progesterone secretion in rabbits [PMID: 3929235]
Laboratory literature summary: Vasoactive intestinal polypeptide stimulates nonovarian progesterone secretion in rabbits. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Delgado M et al. (2001). Cutting edge: is vasoactive intestinal peptide a type 2 cytokine? [PMID: 11207237]
Laboratory literature summary: Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Giachetti A et al. (1979). Axonal transport of vasoactive intestinal peptide in sciatic nerve [PMID: 91110]
Laboratory literature summary: Axonal transport of vasoactive intestinal peptide in sciatic nerve. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mo N et al. (1984). Vasoactive intestinal polypeptide facilitates muscarinic transmission in mammalian… [PMID: 6152040]
Laboratory literature summary: Vasoactive intestinal polypeptide facilitates muscarinic transmission in mammalian sympathetic ganglia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Agha-Mir-Salim S et al. (1991). Presence of vasoactive intestinal peptide receptors in nasal mucosa [PMID: 1662970]
Laboratory literature summary: Presence of vasoactive intestinal peptide receptors in nasal mucosa. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kralios AC et al. (1990). Myocardial electrophysiological effects of vasoactive intestinal peptide in dogs [PMID: 2240253]
Laboratory literature summary: Myocardial electrophysiological effects of vasoactive intestinal peptide in dogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schroeder A et al. (2011). Circadian regulation of cardiovascular function: a role for vasoactive intestinal peptide [PMID: 20952671]
Laboratory literature summary: Circadian regulation of cardiovascular function: a role for vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Smith CH et al. (1992). Cutaneous responses to vasoactive intestinal polypeptide in chronic idiopathic urticaria [PMID: 1370236]
Laboratory literature summary: Cutaneous responses to vasoactive intestinal polypeptide in chronic idiopathic urticaria. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hinson JP et al. (1996). Vasoactive intestinal peptide is a local regulator of adrenocortical function [PMID: 8969946]
Laboratory literature summary: Vasoactive intestinal peptide is a local regulator of adrenocortical function. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Said SI (1982). Vasoactive intestinal peptide in the gut. Physiology and pathology [PMID: 6301189]
Laboratory literature summary: Vasoactive intestinal peptide in the gut. Physiology and pathology. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Itoh S et al. (1985). Antidipsogenic action of vasoactive intestinal peptide in the rat [PMID: 3837859]
Laboratory literature summary: Antidipsogenic action of vasoactive intestinal peptide in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Xin Z et al. (1997). Vasoactive intestinal peptide stimulates p59fyn kinase activity in murine thymocytes [PMID: 9396055]
Laboratory literature summary: Vasoactive intestinal peptide stimulates p59fyn kinase activity in murine thymocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wood CL et al. (1982). Effect of vasoactive intestinal polypeptide on glycogen metabolism in rat hepatocytes [PMID: 6801998]
Laboratory literature summary: Effect of vasoactive intestinal polypeptide on glycogen metabolism in rat hepatocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shaffer MM et al. (1986). Autoradiographic visualization of CNS receptors for vasoactive intestinal peptide [PMID: 3016682]
Laboratory literature summary: Autoradiographic visualization of CNS receptors for vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Paul S et al. (1990). Affinity chromatography of catalytic autoantibody to vasoactive intestinal peptide [PMID: 2380555]
Laboratory literature summary: Affinity chromatography of catalytic autoantibody to vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mody R et al. (1994). Spontaneous hydrolysis of vasoactive intestinal peptide in neutral aqueous solution [PMID: 7896502]
Laboratory literature summary: Spontaneous hydrolysis of vasoactive intestinal peptide in neutral aqueous solution. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kawatani M et al. (1985). Depolarization and muscarinic excitation induced in a sympathetic ganglion by… [PMID: 3895438]
Laboratory literature summary: Depolarization and muscarinic excitation induced in a sympathetic ganglion by vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Maxwell DL et al. (1990). Ventilatory effects of substance P, vasoactive intestinal peptide, and nitroprusside… [PMID: 1690202]
Laboratory literature summary: Ventilatory effects of substance P, vasoactive intestinal peptide, and nitroprusside in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cutz E et al. (1978). Release of vasoactive intestinal polypeptide in mast cells by histamine liberators [PMID: 81468]
Laboratory literature summary: Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mikkelsen JD et al. (1988). Vasoactive intestinal peptide in the hypothalamohypophysial system of the Mongolian gerbil [PMID: 3062045]
Laboratory literature summary: Vasoactive intestinal peptide in the hypothalamohypophysial system of the Mongolian gerbil. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Robichon A et al. (1987). Chemical modification of guanidinium groups of vasoactive intestinal peptide [PMID: 3028489]
Laboratory literature summary: Chemical modification of guanidinium groups of vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Porter JP et al. (1985). Vasoactive intestinal peptide in the regulation of renin secretion [PMID: 3893159]
Laboratory literature summary: Vasoactive intestinal peptide in the regulation of renin secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Misbin RI et al. (1982). Uptake of vasoactive intestinal peptide by rat liver [PMID: 7051851]
Laboratory literature summary: Uptake of vasoactive intestinal peptide by rat liver. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nagy G et al. (1988). Autocrine control of prolactin secretion by vasoactive intestinal peptide [PMID: 3335213]
Laboratory literature summary: Autocrine control of prolactin secretion by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Akasu T et al. (1986). Vasoactive intestinal polypeptide depolarizations in cat bladder parasympathetic ganglia [PMID: 3746700]
Laboratory literature summary: Vasoactive intestinal polypeptide depolarizations in cat bladder parasympathetic ganglia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cunningham LA et al. (1988). Vasoactive intestinal peptide stimulates adrenal aldosterone and corticosterone secretion [PMID: 3359977]
Laboratory literature summary: Vasoactive intestinal peptide stimulates adrenal aldosterone and corticosterone secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Arnaout MA et al. (1986). Vasoactive intestinal polypeptide is synthesized in anterior pituitary tissue [PMID: 3769861]
Laboratory literature summary: Vasoactive intestinal polypeptide is synthesized in anterior pituitary tissue. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Modlin IM et al. (1979). Release of vasoactive intestinal polypeptide from the pancreas [PMID: 538648]
Laboratory literature summary: Release of vasoactive intestinal polypeptide from the pancreas. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Paul S et al. (1985). Autoantibody to vasoactive intestinal peptide in research subjects circulation [PMID: 3839670]
Laboratory literature summary: Autoantibody to vasoactive intestinal peptide in research subjects circulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Machová J (1987). Actions of vasoactive intestinal polypeptide in superior cervical ganglion of the cat [PMID: 3587527]
Laboratory literature summary: Actions of vasoactive intestinal polypeptide in superior cervical ganglion of the cat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dey RD et al. (1993). Origin of galanin in nerves of cat airways and colocalization with vasoactive… [PMID: 7689936]
Laboratory literature summary: Origin of galanin in nerves of cat airways and colocalization with vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Viron B et al. (1989). Plasma vasoactive intestinal peptide in uremic research subjects [PMID: 2722282]
Laboratory literature summary: Plasma vasoactive intestinal peptide in uremic research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Keltz TN et al. (1980). Degradation of vasoactive intestinal polypeptide by tissue homogenates [PMID: 7356489]
Laboratory literature summary: Degradation of vasoactive intestinal polypeptide by tissue homogenates. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Okumura N et al. (1994). Vasoactive intestinal peptide induces tyrosine phosphorylation in PC12h cells [PMID: 7822252]
Laboratory literature summary: Vasoactive intestinal peptide induces tyrosine phosphorylation in PC12h cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mitchell CH et al. (1976). Intractable watery diarrhea, ganglioneuroblastoma, and vasoactive intestinal peptide [PMID: 957001]
Laboratory literature summary: Intractable watery diarrhea, ganglioneuroblastoma, and vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Durham JH et al. (1987). Vasoactive intestinal peptide stimulates alkali excretion in turtle urinary bladder [PMID: 2436484]
Laboratory literature summary: Vasoactive intestinal peptide stimulates alkali excretion in turtle urinary bladder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Taylor AR et al. (1977). Adrenal oncology research models secreting vasoactive intestinal peptide and noradrenaline [PMID: 596587]
Laboratory literature summary: Adrenal oncology research models secreting vasoactive intestinal peptide and noradrenaline. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kaplan SJ et al. (1980). Vasoactive intestinal peptide secreting tumors of childhood [PMID: 6101297]
Laboratory literature summary: Vasoactive intestinal peptide secreting tumors of childhood. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Williams JT et al. (1979). Vasoactive intestinal polypeptide excites neurones of the myenteric plexus [PMID: 487147]
Laboratory literature summary: Vasoactive intestinal polypeptide excites neurones of the myenteric plexus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Raingeaud J et al. (1996). Production, analysis and bioactivity of recombinant vasoactive intestinal peptide analogs [PMID: 8725006]
Laboratory literature summary: Production, analysis and bioactivity of recombinant vasoactive intestinal peptide analogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hachisu M et al. (1991). Enzymatic degradation of helodermin and vasoactive intestinal polypeptide [PMID: 1652635]
Laboratory literature summary: Enzymatic degradation of helodermin and vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chayvialle JA et al. (1980). Release of vasoactive intestinal peptide by distention of the proximal stomach in dogs [PMID: 7429339]
Laboratory literature summary: Release of vasoactive intestinal peptide by distention of the proximal stomach in dogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jivegård L et al. (1989). Vasoactive intestinal peptide in the normal and inflamed feline gallbladder [PMID: 2756154]
Laboratory literature summary: Vasoactive intestinal peptide in the normal and inflamed feline gallbladder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Heistad DD et al. (1980). Effect of acetylcholine and vasoactive intestinal peptide on cerebral blood flow [PMID: 7396021]
Laboratory literature summary: Effect of acetylcholine and vasoactive intestinal peptide on cerebral blood flow. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
McCulloch J et al. (1983). A functional role for vasoactive intestinal polypeptide in anterior cingulate cortex [PMID: 6877366]
Laboratory literature summary: A functional role for vasoactive intestinal polypeptide in anterior cingulate cortex. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shreeve SM et al. (1996). Vasoactive intestinal peptide activates both Gs and Gi in lung [PMID: 8993433]
Laboratory literature summary: Vasoactive intestinal peptide activates both Gs and Gi in lung. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sycamnias J et al. (2009). A case of vasoactive intestinal polypeptideoma [PMID: 19652683]
Laboratory literature summary: A case of vasoactive intestinal polypeptideoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Luine VN et al. (1984). Activation of choline acetyltransferase by vasoactive intestinal peptide [PMID: 6321660]
Laboratory literature summary: Activation of choline acetyltransferase by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Porter JP et al. (1982). Stimulation of renin secretion by vasoactive intestinal peptide [PMID: 7051858]
Laboratory literature summary: Stimulation of renin secretion by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jégou S et al. (1988). Regional distribution of vasoactive intestinal peptide in brains from normal and… [PMID: 3226955]
Laboratory literature summary: Regional distribution of vasoactive intestinal peptide in brains from normal and neurodegeneration research models subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gu J et al. (1983). Vasoactive intestinal polypeptide in the normal and unstable bladder [PMID: 6360296]
Laboratory literature summary: Vasoactive intestinal polypeptide in the normal and unstable bladder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bloom SR (1975). Proceedings: Vasoactive intestinal peptide and the Verner-Morrison syndrome [PMID: 166903]
Laboratory literature summary: Proceedings: Vasoactive intestinal peptide and the Verner-Morrison syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wesley JR et al. (1982). A new syndrome of symptomatic cutaneous mastocytoma producing vasoactive intestinal… [PMID: 6800875]
Laboratory literature summary: A new syndrome of symptomatic cutaneous mastocytoma producing vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sekizawa K et al. (1988). Modulation of cholinergic neurotransmission by vasoactive intestinal peptide in ferret… [PMID: 2841273]
Laboratory literature summary: Modulation of cholinergic neurotransmission by vasoactive intestinal peptide in ferret trachea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Morice AH et al. (1984). Vasoactive intestinal peptide as a bronchodilator in asthmatic subjects [PMID: 6382197]
Laboratory literature summary: Vasoactive intestinal peptide as a bronchodilator in asthmatic subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Polak JM et al. (1975). Proceedings: Vasoactive intestinal peptide characteristics in research subjects gut [PMID: 1107177]
Laboratory literature summary: Proceedings: Vasoactive intestinal peptide characteristics in research subjects gut. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rigel DF et al. (1991). Vasoactive intestinal polypeptide enhances automaticity of supraventricular pacemakers… [PMID: 1877672]
Laboratory literature summary: Vasoactive intestinal polypeptide enhances automaticity of supraventricular pacemakers in anesthetized dogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Morgan CW et al. (1999). Vasoactive intestinal polypeptide in sacral primary sensory pathways in the cat [PMID: 10320218]
Laboratory literature summary: Vasoactive intestinal polypeptide in sacral primary sensory pathways in the cat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lam KS et al. (1989). Vasoactive intestinal peptide in the anterior pituitary is increased in hypothyroidism [PMID: 2912685]
Laboratory literature summary: Vasoactive intestinal peptide in the anterior pituitary is increased in hypothyroidism. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ito O et al. (1991). Vasoactive intestinal polypeptide precursors have highly potent bronchodilatory activity [PMID: 2052489]
Laboratory literature summary: Vasoactive intestinal polypeptide precursors have highly potent bronchodilatory activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Blitz W et al. (1983). Regional vascular influences of vasoactive intestinal polypeptide [PMID: 6669940]
Laboratory literature summary: Regional vascular influences of vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Eng J et al. (1989). Purification of neuropeptides: cholecystokinin and vasoactive intestinal peptide [PMID: 2725305]
Laboratory literature summary: Purification of neuropeptides: cholecystokinin and vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Weinstock JV et al. (1990). Detection of vasoactive intestinal peptide and localization of its mRNA within… [PMID: 2297792]
Laboratory literature summary: Detection of vasoactive intestinal peptide and localization of its mRNA within granulomas of murine schistosomiasis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhu J et al. (2011). [Progress of studies on regulative effect of acupuncture on activities of vasoactive… [PMID: 22379794]
Laboratory literature summary: [Progress of studies on regulative effect of acupuncture on activities of vasoactive intestinal peptide]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Konturek SJ et al. (1976). Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic… [PMID: 1255530]
Laboratory literature summary: Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Suzuki R et al. (1983). Vasoactive intestinal peptide and cholinergic neurotransmission in the ciliary muscle [PMID: 6826329]
Laboratory literature summary: Vasoactive intestinal peptide and cholinergic neurotransmission in the ciliary muscle. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Funakoshi A et al. (1989). Vasoactive intestinal polypeptide stimulates cholecystokinin secretion in perfused rat… [PMID: 2711376]
Laboratory literature summary: Vasoactive intestinal polypeptide stimulates cholecystokinin secretion in perfused rat duodenum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Okada K et al. (1995). Vasoactive intestinal contractor as a genesis of renal hypertension [PMID: 7723902]
Laboratory literature summary: Vasoactive intestinal contractor as a genesis of renal hypertension. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kimata H et al. (1994). Vasoactive intestinal peptide specifically induces research subjects IgA1 and IgA2… [PMID: 7522170]
Laboratory literature summary: Vasoactive intestinal peptide specifically induces research subjects IgA1 and IgA2 production. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Calam J et al. (1983). Effects of vasoactive intestinal polypeptide on renal function in man [PMID: 6363677]
Laboratory literature summary: Effects of vasoactive intestinal polypeptide on renal function in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Paul S et al. (1991). Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies [PMID: 1874750]
Laboratory literature summary: Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
D'Amato M et al. (1992). Release of vasoactive intestinal polypeptide from the rat gastric fundus [PMID: 1352721]
Laboratory literature summary: Release of vasoactive intestinal polypeptide from the rat gastric fundus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fuortes M et al. (1988). Release of vasoactive intestinal peptide during hyperdynamic sepsis in dogs [PMID: 3187902]
Laboratory literature summary: Release of vasoactive intestinal peptide during hyperdynamic sepsis in dogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Savage MV et al. (1990). Cystic fibrosis, vasoactive intestinal polypeptide, and active cutaneous vasodilation [PMID: 1706332]
Laboratory literature summary: Cystic fibrosis, vasoactive intestinal polypeptide, and active cutaneous vasodilation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rodríguez-Henche N et al. (1994). Characterization of vasoactive intestinal peptide receptors in research subjects liver [PMID: 8148398]
Laboratory literature summary: Characterization of vasoactive intestinal peptide receptors in research subjects liver. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sninsky CA et al. (1983). Myoelectric effects of vasoactive intestinal peptide on rabbit small intestine [PMID: 6849393]
Laboratory literature summary: Myoelectric effects of vasoactive intestinal peptide on rabbit small intestine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sakakibara H et al. (1994). Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages [PMID: 7943252]
Laboratory literature summary: Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Samson WK et al. (1980). In vitro stimulation of prolactin release by vasoactive intestinal peptide [PMID: 7301635]
Laboratory literature summary: In vitro stimulation of prolactin release by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hart R et al. (1988). [Vasoactive intestinal polypeptide influences research subjects immunoglobulin secretion] [PMID: 3366076]
Laboratory literature summary: [Vasoactive intestinal polypeptide influences research subjects immunoglobulin secretion]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Camilleri M et al. (1981). Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine [PMID: 6257593]
Laboratory literature summary: Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cugini P et al. (1990). Vasoactive intestinal peptide is a biorhythmic variable of research subjects blood [PMID: 2291024]
Laboratory literature summary: Vasoactive intestinal peptide is a biorhythmic variable of research subjects blood. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Falsetti L et al. (1989). Vasoactive intestinal polypeptide loses its prolactin-releasing activity in menopausal… [PMID: 2606965]
Laboratory literature summary: Vasoactive intestinal polypeptide loses its prolactin-releasing activity in menopausal research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sagor GR et al. (1981). Release of vasoactive intestinal peptide in the dumping syndrome [PMID: 6780101]
Laboratory literature summary: Release of vasoactive intestinal peptide in the dumping syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kiso T et al. (1994). Characterization of vasoactive intestinal peptide receptors in canine liver membranes [PMID: 8304967]
Laboratory literature summary: Characterization of vasoactive intestinal peptide receptors in canine liver membranes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hohmann EL et al. (1984). Functional receptors for vasoactive intestinal peptide on research subjects oncology… [PMID: 6323142]
Laboratory literature summary: Functional receptors for vasoactive intestinal peptide on research subjects oncology research models cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kerins C et al. (1973). Hyperglycemic and glycogenolytic effects of vasoactive intestinal polypeptide [PMID: 4691998]
Laboratory literature summary: Hyperglycemic and glycogenolytic effects of vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderson FL et al. (1993). Release of vasoactive intestinal peptide and neuropeptide Y from canine heart [PMID: 8214133]
Laboratory literature summary: Release of vasoactive intestinal peptide and neuropeptide Y from canine heart. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Virgolini I et al. (1998). Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy [PMID: 9744346]
Laboratory literature summary: Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Epelbaum J et al. (1979). Vasoactive intestinal peptide inhibits release of somatostatin from hypothalamus in vitro [PMID: 510382]
Laboratory literature summary: Vasoactive intestinal peptide inhibits release of somatostatin from hypothalamus in vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pacheco-Cano MT et al. (1990). Vasoactive intestinal polypeptide induces REM recovery in insomniac forebrain lesioned… [PMID: 2267473]
Laboratory literature summary: Vasoactive intestinal polypeptide induces REM recovery in insomniac forebrain lesioned cats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Duggan KA et al. (1989). Sodium depletion decreases hepatic metabolism of vasoactive intestinal peptide in the… [PMID: 2621618]
Laboratory literature summary: Sodium depletion decreases hepatic metabolism of vasoactive intestinal peptide in the rabbit. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
McCulloch J et al. (1980). Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide [PMID: 7377315]
Laboratory literature summary: Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Smith ER et al. (1984). Effects of vasoactive intestinal peptide on canine prostatic contraction and secretion [PMID: 6388351]
Laboratory literature summary: Effects of vasoactive intestinal peptide on canine prostatic contraction and secretion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ottaway CA (1992). Receptors for vasoactive intestinal peptide on murine lymphocytes turn over rapidly [PMID: 1318321]
Laboratory literature summary: Receptors for vasoactive intestinal peptide on murine lymphocytes turn over rapidly. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Reid AM et al. (1988). The effects of vasoactive intestinal polypeptide on gastric motility in the lamb [PMID: 2900891]
Laboratory literature summary: The effects of vasoactive intestinal polypeptide on gastric motility in the lamb. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ozbay A et al. (2008). Adrenal pheochromocytoma producing vasoactive intestinal peptide and masking hypertension [PMID: 18663320]
Laboratory literature summary: Adrenal pheochromocytoma producing vasoactive intestinal peptide and masking hypertension. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Enyedi P et al. (1983). Failure of vasoactive intestinal peptide to stimulate aldosterone production [PMID: 6637524]
Laboratory literature summary: Failure of vasoactive intestinal peptide to stimulate aldosterone production. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kane MG et al. (1983). Production of secretory diarrhea by intravenous infusion of vasoactive intestinal… [PMID: 6316136]
Laboratory literature summary: Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tolentino PJ et al. (1996). Regulation of vasoactive intestinal polypeptide and galanin mRNA stabilities [PMID: 8804717]
Laboratory literature summary: Regulation of vasoactive intestinal polypeptide and galanin mRNA stabilities. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Siow Y et al. (1999). Effects of vasoactive intestinal peptide on research subjects sperm motility [PMID: 10445106]
Laboratory literature summary: Effects of vasoactive intestinal peptide on research subjects sperm motility. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bojö L et al. (1993). Involvement of vasoactive intestinal polypeptide in gastric reflex relaxation [PMID: 8359202]
Laboratory literature summary: Involvement of vasoactive intestinal polypeptide in gastric reflex relaxation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Unverferth DV et al. (1985). Effect of vasoactive intestinal polypeptide on the canine cardiovascular system [PMID: 4056568]
Laboratory literature summary: Effect of vasoactive intestinal polypeptide on the canine cardiovascular system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gonzales SM et al. (1995). Presence of vasoactive intestinal peptide receptor in the hen hypothalamus [PMID: 7627262]
Laboratory literature summary: Presence of vasoactive intestinal peptide receptor in the hen hypothalamus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sánchez V et al. (1991). Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo [PMID: 2065763]
Laboratory literature summary: Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schebalin M et al. (1977). Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide [PMID: 320878]
Laboratory literature summary: Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Duggan KA et al. (1990). Regulation of vasoactive intestinal peptide release and metabolism by sodium [PMID: 1708016]
Laboratory literature summary: Regulation of vasoactive intestinal peptide release and metabolism by sodium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wolfe MM et al. (1983). Enteric release of vasoactive intestinal peptide after a peptone meal in the dog [PMID: 6828775]
Laboratory literature summary: Enteric release of vasoactive intestinal peptide after a peptone meal in the dog. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wechsung E et al. (1994). Effect of vasoactive intestinal polypeptide on porcine gastrointestinal electrical… [PMID: 7700839]
Laboratory literature summary: Effect of vasoactive intestinal polypeptide on porcine gastrointestinal electrical activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Paul S et al. (1987). Characterization of receptors for vasoactive intestinal peptide solubilized from the lung [PMID: 3025200]
Laboratory literature summary: Characterization of receptors for vasoactive intestinal peptide solubilized from the lung. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Low AM et al. (1997). Mobilization of internal Ca2+ by vasoactive intestinal polypeptide in endothelial cells [PMID: 9473140]
Laboratory literature summary: Mobilization of internal Ca2+ by vasoactive intestinal polypeptide in endothelial cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fournier A et al. (1988). Conformational analysis of vasoactive intestinal peptide and related fragments [PMID: 3389647]
Laboratory literature summary: Conformational analysis of vasoactive intestinal peptide and related fragments. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hattori Y et al. (1992). Glibenclamide does not block arterial relaxation caused by vasoactive intestinal… [PMID: 1499652]
Laboratory literature summary: Glibenclamide does not block arterial relaxation caused by vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Davis JP et al. (1987). Trigeminal ganglion cells cocultured with gut express vasoactive intestinal peptide [PMID: 3500079]
Laboratory literature summary: Trigeminal ganglion cells cocultured with gut express vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Itoh S et al. (1988). Effect of vasoactive intestinal peptide on dopaminergic system in the rat brain [PMID: 3375138]
Laboratory literature summary: Effect of vasoactive intestinal peptide on dopaminergic system in the rat brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gardner DF et al. (1985). Preferential binding of vasoactive intestinal peptide to hepatic nonparenchymal cells [PMID: 2988343]
Laboratory literature summary: Preferential binding of vasoactive intestinal peptide to hepatic nonparenchymal cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang Y et al. (1995). Purification and structural characterization of vasoactive intestinal polypeptide from… [PMID: 7781967]
Laboratory literature summary: Purification and structural characterization of vasoactive intestinal polypeptide from the trout and bowfin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jensen RJ (1993). Effects of vasoactive intestinal peptide on ganglion cells in the rabbit retina [PMID: 8424925]
Laboratory literature summary: Effects of vasoactive intestinal peptide on ganglion cells in the rabbit retina. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gold MR (1982). The effects of vasoactive intestinal peptide on neuromuscular transmission in the frog [PMID: 6288927]
Laboratory literature summary: The effects of vasoactive intestinal peptide on neuromuscular transmission in the frog. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nandiwada PA et al. (1985). Pulmonary vasodilator responses to vasoactive intestinal peptide in the cat [PMID: 3997734]
Laboratory literature summary: Pulmonary vasodilator responses to vasoactive intestinal peptide in the cat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bernhard W et al. (1989). Degradation of vasoactive intestinal peptide by isolated, ventilated, and perfused rat… [PMID: 2515970]
Laboratory literature summary: Degradation of vasoactive intestinal peptide by isolated, ventilated, and perfused rat lungs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bouder TG et al. (1988). Effects of vasoactive intestinal peptide on vascular conductance are unaffected by… [PMID: 3202229]
Laboratory literature summary: Effects of vasoactive intestinal peptide on vascular conductance are unaffected by anesthesia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nagashima F et al. (1993). Silent mixed ganglioneuroma/pheochromocytoma which produces a vasoactive intestinal… [PMID: 8495050]
Laboratory literature summary: Silent mixed ganglioneuroma/pheochromocytoma which produces a vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Graham DY et al. (1975). Islet cell carcinoma, pancreatic cholera, and vasoactive intestinal peptide [PMID: 173221]
Laboratory literature summary: Islet cell carcinoma, pancreatic cholera, and vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Robberecht P et al. (1979). Specificity of receptors to vasoactive intestinal peptide in guinea pig brain [PMID: 226824]
Laboratory literature summary: Specificity of receptors to vasoactive intestinal peptide in guinea pig brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Suzuki H et al. (1995). Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation… [PMID: 7674836]
Laboratory literature summary: Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation in vivo. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chihara K et al. (1984). Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly [PMID: 6417157]
Laboratory literature summary: Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frase LL et al. (1984). Effect of vasoactive intestinal polypeptide infusion on cardiovascular function in man [PMID: 11540860]
Laboratory literature summary: Effect of vasoactive intestinal polypeptide infusion on cardiovascular function in man. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wei EP et al. (1980). Mechanism of action of vasoactive intestinal polypeptide on cerebral arterioles [PMID: 7446750]
Laboratory literature summary: Mechanism of action of vasoactive intestinal polypeptide on cerebral arterioles. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nordlind K et al. (1992). Protecting effects of vasoactive intestinal polypeptide on lymphocytes against metal… [PMID: 1597659]
Laboratory literature summary: Protecting effects of vasoactive intestinal polypeptide on lymphocytes against metal toxicity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cuervo L et al. (1994). Immunoreactivity to chromogranin and to vasoactive intestinal peptide in a canine… [PMID: 7836575]
Laboratory literature summary: Immunoreactivity to chromogranin and to vasoactive intestinal peptide in a canine phaeochromocytoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Long RG et al. (1981). Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting… [PMID: 6786616]
Laboratory literature summary: Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Altiere RJ et al. (1983). Relaxant effects of vasoactive intestinal peptide and bethanechol in cat… [PMID: 6138270]
Laboratory literature summary: Relaxant effects of vasoactive intestinal peptide and bethanechol in cat intrapulmonary artery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fahrenkrug J et al. (1982). Nervous release of vasoactive intestinal polypeptide from the feline uterus:… [PMID: 7153911]
Laboratory literature summary: Nervous release of vasoactive intestinal polypeptide from the feline uterus: pharmacological characteristics. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Venugopalan CS et al. (1984). Effect of vasoactive intestinal peptide on vagally mediated tracheal pouch relaxation [PMID: 6463427]
Laboratory literature summary: Effect of vasoactive intestinal peptide on vagally mediated tracheal pouch relaxation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frawley LS et al. (1981). Stimulation of prolactin secretion in rhesus monkeys by vasoactive intestinal polypeptide [PMID: 7266772]
Laboratory literature summary: Stimulation of prolactin secretion in rhesus monkeys by vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rolandi E et al. (1987). Possible role of vasoactive intestinal polypeptide on prolactin release during… [PMID: 3436618]
Laboratory literature summary: Possible role of vasoactive intestinal polypeptide on prolactin release during suckling in lactating research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Qiu JF et al. (2007). [Protective effects of vasoactive intestinal peptide on septic shock rats] [PMID: 17498382]
Laboratory literature summary: [Protective effects of vasoactive intestinal peptide on septic shock rats]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Seilicovich A et al. (1991). Possible role of vasoactive intestinal peptide in the hyperprolactinemia induced by… [PMID: 2047543]
Laboratory literature summary: Possible role of vasoactive intestinal peptide in the hyperprolactinemia induced by ethanol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Larsson LI et al. (1979). On the immunocytochemical localization of the vasoactive intestinal polypeptide [PMID: 479555]
Laboratory literature summary: On the immunocytochemical localization of the vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shaar CJ et al. (1979). Effect of vasoactive intestinal polypeptide on prolactin release in vitro [PMID: 537469]
Laboratory literature summary: Effect of vasoactive intestinal polypeptide on prolactin release in vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang W et al. (2007). [Immunoregulation of vasoactive intestinal peptide on rat Leydig cells] [PMID: 17618557]
Laboratory literature summary: [Immunoregulation of vasoactive intestinal peptide on rat Leydig cells]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gjerris A et al. (1984). Catecholamines and vasoactive intestinal polypeptide in cerebrospinal fluid in depression [PMID: 6464828]
Laboratory literature summary: Catecholamines and vasoactive intestinal polypeptide in cerebrospinal fluid in depression. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhang X et al. (1997). Effect of acupuncture on vasoactive intestinal peptide in ischemic cerebrovascular… [PMID: 10437215]
Laboratory literature summary: Effect of acupuncture on vasoactive intestinal peptide in ischemic cerebrovascular diseases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Caniano DA et al. (1986). Functional response to vasoactive intestinal peptide in piebald lethal mice [PMID: 3794977]
Laboratory literature summary: Functional response to vasoactive intestinal peptide in piebald lethal mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nexø E et al. (1987). Salivary secretion of rat haptocorrin and amylase is stimulated by vasoactive… [PMID: 2435597]
Laboratory literature summary: Salivary secretion of rat haptocorrin and amylase is stimulated by vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Strunz UT et al. (1977). Lack of hepatic inactivation of canine vasoactive intestinal peptide [PMID: 892380]
Laboratory literature summary: Lack of hepatic inactivation of canine vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Revhaug A et al. (1985). Increased plasma levels of vasoactive intestinal polypeptide in pigs during endotoxinaemia [PMID: 3884342]
Laboratory literature summary: Increased plasma levels of vasoactive intestinal polypeptide in pigs during endotoxinaemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Itoh T et al. (1985). Mechanisms of vasodilation induced by vasoactive intestinal polypeptide in rabbit… [PMID: 2992292]
Laboratory literature summary: Mechanisms of vasodilation induced by vasoactive intestinal polypeptide in rabbit mesenteric artery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Guijarro L et al. (1989). Solubilization of active and stable receptors for vasoactive intestinal peptide from… [PMID: 2541470]
Laboratory literature summary: Solubilization of active and stable receptors for vasoactive intestinal peptide from rat liver. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fukuda M et al. (1981). Localization of vasoactive intestinal polypeptide and neurotensin immunoreactivities… [PMID: 7028400]
Laboratory literature summary: Localization of vasoactive intestinal polypeptide and neurotensin immunoreactivities in the avian retina. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Goetzl EJ et al. (1989). Unique pattern of cleavage of vasoactive intestinal peptide by research subjects… [PMID: 2654011]
Laboratory literature summary: Unique pattern of cleavage of vasoactive intestinal peptide by research subjects lymphocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Unverferth DV et al. (1986). Research subjects and canine ventricular vasoactive intestinal polypeptide: decrease… [PMID: 3711722]
Laboratory literature summary: research subjects and canine ventricular vasoactive intestinal polypeptide: decrease with heart failure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lucia P et al. (1996). Early increase of vasoactive intestinal peptide in acute myocardial infarction [PMID: 8701862]
Laboratory literature summary: Early increase of vasoactive intestinal peptide in acute myocardial infarction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Husain K et al. (2011). Mediastinal ganglioneuroblastoma-secreting vasoactive intestinal peptide causing… [PMID: 21684485]
Laboratory literature summary: Mediastinal ganglioneuroblastoma-secreting vasoactive intestinal peptide causing secretory diarrhoea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gonda T et al. (1995). Hyperplastic innervation of vasoactive intestinal peptide in research subjects… [PMID: 7579816]
Laboratory literature summary: Hyperplastic innervation of vasoactive intestinal peptide in research subjects gallbladder with cholelithiasis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shen ZJ (2005). [Progress in the studies of vasoactive intestinal polypeptide] [PMID: 16078660]
Laboratory literature summary: [Progress in the studies of vasoactive intestinal polypeptide]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yang J et al. (2007). [Neuroprotective effects of vasoactive intestinal peptide against rat cerebral ischemia] [PMID: 18158987]
Laboratory literature summary: [Neuroprotective effects of vasoactive intestinal peptide against rat cerebral ischemia]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shibusawa K (1983). [Koro in India. Vasoactive intestinal peptide hormone] [PMID: 6555410]
Laboratory literature summary: [Koro in India. Vasoactive intestinal peptide hormone]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mutt V (1981). Additional observations on cholecystokinin and the vasoactive intestinal polypeptide [PMID: 6283492]
Laboratory literature summary: Additional observations on cholecystokinin and the vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
White RP (1987). Responses of research subjects basilar arteries to vasoactive intestinal polypeptide [PMID: 3475521]
Laboratory literature summary: Responses of research subjects basilar arteries to vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Scholar EM et al. (1991). Stimulation of oncology research models cell growth by vasoactive intestinal peptide [PMID: 2001545]
Laboratory literature summary: Stimulation of oncology research models cell growth by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dimaline R et al. (1979). Molecular variants of vasoactive intestinal polypeptide in dog, rat and hog [PMID: 529992]
Laboratory literature summary: Molecular variants of vasoactive intestinal polypeptide in dog, rat and hog. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tsuji M et al. (1987). Laboratory research record on VIP (Vasoactive Intestinal ) [PMID: 3655491]
PubMed laboratory record discussing VIP (Vasoactive Intestinal ) in a research context. Review the full methods and limitations on PubMed; research use only.
Guan CX et al. (2002). [Effects of vasoactive intestinal peptide on chemotaxis of bronchial epithelial cells] [PMID: 11973586]
Laboratory literature summary: [Effects of vasoactive intestinal peptide on chemotaxis of bronchial epithelial cells]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Konturek SJ et al. (1975). Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs [PMID: 1132634]
Laboratory literature summary: Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bardrum B et al. (1988). Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal… [PMID: 3168920]
Laboratory literature summary: Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Leonardi R et al. (1981). [Vasoactive intestinal polypeptide in digestive processes in the Verner Morrison syndrome] [PMID: 6265832]
Laboratory literature summary: [Vasoactive intestinal polypeptide in digestive processes in the Verner Morrison syndrome]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vytiska-Binstorfer E et al. (1987). [Stimulation of prolactin secretion by vasoactive intestinal peptide] [PMID: 3115863]
Laboratory literature summary: [Stimulation of prolactin secretion by vasoactive intestinal peptide]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dimaline R et al. (1980). Characterization and distribution of molecular variants of vasoactive intestinal… [PMID: 7014207]
Laboratory literature summary: Characterization and distribution of molecular variants of vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shulkes A et al. (1987). Laboratory research record on VIP (Vasoactive Intestinal ) [PMID: 3651537]
PubMed laboratory record discussing VIP (Vasoactive Intestinal ) in a research context. Review the full methods and limitations on PubMed; research use only.
Yang J et al. (2009). [Vasoactive intestinal peptide enhances angiogenesis after focal cerebral ischemia] [PMID: 19403378]
Laboratory literature summary: [Vasoactive intestinal peptide enhances angiogenesis after focal cerebral ischemia]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gafvelin G et al. (1988). Isolation and characterization of a variant form of vasoactive intestinal polypeptide [PMID: 2843830]
Laboratory literature summary: Isolation and characterization of a variant form of vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ernström U et al. (1995). Rescue of thymocytes from cell death by vasoactive intestinal peptide [PMID: 7659793]
Laboratory literature summary: Rescue of thymocytes from cell death by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frandsen EK et al. (1973). Lipolytic action of a newly isolated vasoactive intestinal polypeptide [PMID: 4714546]
Laboratory literature summary: Lipolytic action of a newly isolated vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bolin DR et al. (1996). Comparison of cyclic and linear analogs of vasoactive intestinal peptide [PMID: 8874048]
Laboratory literature summary: Comparison of cyclic and linear analogs of vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nilsson C et al. (1991). Epithelial cells purified from choroid plexus have receptors for vasoactive intestinal… [PMID: 1851455]
Laboratory literature summary: Epithelial cells purified from choroid plexus have receptors for vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Edvinsson L et al. (1979). Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide… [PMID: 113530]
Laboratory literature summary: Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide [proceedings]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jovanovic S et al. (2000). Developmental research context does not alter the response of uterine arteries to… [PMID: 10729319]
Laboratory literature summary: developmental research context does not alter the response of uterine arteries to vasoactive intestinal polypeptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Itoh H et al. (1990). Relaxation of isolated bovine coronary arteries by vasoactive intestinal peptide [PMID: 2384132]
Laboratory literature summary: Relaxation of isolated bovine coronary arteries by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rorstad OP et al. (1990). Selectivity for binding of peptide analogs to vascular receptors for vasoactive… [PMID: 2163020]
Laboratory literature summary: Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Swift PG et al. (1975). Watery diarrhoea and ganglioneuroma with secretion of vasoactive intestinal peptide [PMID: 1211964]
Laboratory literature summary: Watery diarrhoea and ganglioneuroma with secretion of vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bardrum B et al. (1987). Preferential release of oxytocin in response to vasoactive intestinal polypeptide in rats [PMID: 3796218]
Laboratory literature summary: Preferential release of oxytocin in response to vasoactive intestinal polypeptide in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Opel H et al. (1988). Stimulation of prolactin release in turkeys by vasoactive intestinal peptide [PMID: 3353394]
Laboratory literature summary: Stimulation of prolactin release in turkeys by vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Achord JL (1986). Secretin, cholecystokinin, and vasoactive intestinal polypeptide in pancreatic cholera [PMID: 3019205]
Laboratory literature summary: Secretin, cholecystokinin, and vasoactive intestinal polypeptide in pancreatic cholera. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ohkawa R (1990). [The effect of vasoactive intestinal peptide on the rat ovary] [PMID: 2170209]
Laboratory literature summary: [The effect of vasoactive intestinal peptide on the rat ovary]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Milenov K et al. (1995). Effects of cholecystokinine on the gallbladder motility: interaction with somatostatin… [PMID: 8868369]
Laboratory literature summary: Effects of cholecystokinine on the gallbladder motility: interaction with somatostatin and vasoactive intestinal peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li X et al. (1990). [The relation of vasoactive intestinal peptide and acute hypoxia] [PMID: 2401169]
Laboratory literature summary: [The relation of vasoactive intestinal peptide and acute hypoxia]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Riou F et al. (1981). [Hypnogenic properties of the vasoactive intestinal polypeptide in rats] [PMID: 6460548]
Laboratory literature summary: [Hypnogenic properties of the vasoactive intestinal polypeptide in rats]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhag SL et al. (2007). [A case report of vasoactive intestinal Peptide tumors] [PMID: 17927869]
Laboratory literature summary: [A case report of vasoactive intestinal Peptide tumors]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sakio H (1983). [Study on the release of vasoactive intestinal polypeptide during hemorrhagic shock] [PMID: 6842817]
Laboratory literature summary: [Study on the release of vasoactive intestinal polypeptide during hemorrhagic shock]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bourgois B et al. (2004). [Intractable diarrhoea revealing a neuroblastoma hypersecreting the vasoactive… [PMID: 15051093]
Laboratory literature summary: [Intractable diarrhoea revealing a neuroblastoma hypersecreting the vasoactive intestinal peptide]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brunet J et al. (1988). [Metastatic neuroblastoma with secondary hypersecretion of vasoactive intestinal peptide] [PMID: 3200652]
Laboratory literature summary: [Metastatic neuroblastoma with secondary hypersecretion of vasoactive intestinal peptide]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jakober B et al. (1984). [Hormone active oncology research models with production of vasoactive intestinal… [PMID: 6700414]
Laboratory literature summary: [Hormone active oncology research models with production of vasoactive intestinal polypeptide]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight	.125 lbs
Dimensions	8 × 7 × .5 in
Size: No selection	5mg, 10mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is VIP (Vasoactive Intestinal Peptide)?

VIP is a neuropeptide composed of 28 amino acids. It is studied in research laboratories for its role in cellular signaling, receptor activity, and neuroendocrine pathways.

What is VIP used for in research?

VIP is used in research laboratories to investigate receptor binding, peptide signaling, and neuroendocrine mechanisms. It is not approved for human use.

Is VIP (Vasoactive Intestinal Peptide) Peptide approved or intended for human use?

No. VIP is strictly intended for research purposes only and is not approved by the FDA for human use.

Is VIP (Vasoactive Intestinal Peptide) Peptide FDA-approved for medical or clinical use?

No. VIP is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is VIP supplied?

VIP is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should VIP be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for VIP?

VIP is available in multiple vial sizes (e.g., 5mg, 10mg).

Is VIP (Vasoactive Intestinal Peptide) Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is VIP shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments

How can I verify VIP purity and quality?

Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency. For more info, visit: https://www.nationwidepeptides.com/coa/

Frequently bought together

VIP (Vasoactive Intestinal Peptide) Peptide

Bacteriostatic Water (Bac Water) research-grade

Bacteriostatic Water (Bac Water) - 10ml

$16.00

	Product		Price
	Bacteriostatic Water (Bac Water) - 10ml
	VIP (Vasoactive Intestinal Peptide) Peptide

Frequently Asked Questions

What is VIP (Vasoactive Intestinal Peptide)?

VIP is a neuropeptide composed of 28 amino acids. It is studied in research laboratories for its role in cellular signaling, receptor activity, and neuroendocrine pathways.

What is VIP used for in research?

VIP is used in research laboratories to investigate receptor binding, peptide signaling, and neuroendocrine mechanisms. It is not approved for human use.

Is VIP (Vasoactive Intestinal Peptide) Peptide approved or intended for human use?

No. VIP is strictly intended for research purposes only and is not approved by the FDA for human use.

Is VIP (Vasoactive Intestinal Peptide) Peptide FDA-approved for medical or clinical use?

No. VIP is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is VIP supplied?

VIP is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should VIP be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for VIP?

VIP is available in multiple vial sizes (e.g., 5mg, 10mg).

Is VIP (Vasoactive Intestinal Peptide) Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is VIP shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments

How can I verify VIP purity and quality?

Follow Us

Want to chat?

VIP (Vasoactive Intestinal Peptide) Peptide

Overview

Research Context for VIP (Vasoactive Intestinal Peptide) Peptide

Documented Attributes